🏷

Classifications

Harrison's Part

📘

Definitions

2

Self-limited familial infantile epilepsy clinical definition

A clinical syndrome of unprovoked focal seizures or focal-to-bilateral tonic-clonic seizures beginning in infancy, commonly in clusters, in a usually normally developing child with a compatible autosomal dominant family history and remission in early childhood. Molecular confirmation refines the subtype but is not required to recognize the electroclinical syndrome.

CASE_DEFINITION Infants and families with a self-limited focal epilepsy beginning after the neonatal period

Show evidence (2 references)

PMID:31901402 SUPPORT Human Clinical

"Self-limited (familial) infantile epilepsy (S(F)IE), formerly known as benign (familial) infantile convulsions (B(F)IC), is an infantile cluster epilepsy with in rule a complete recovery."

This cohort defines the syndrome using current terminology, infantile clustering, and recovery.

PMID:36775847 SUPPORT Human Clinical

"Patients with PRRT2-related epilepsy had characteristic seizure semiology at the initial presentation, including all afebrile, clustered (n = 23, 63.9%), short-duration (n = 33, 91.7%), and bilateral tonic-clonic seizures (n = 26, 72.2%)."

A genetically confirmed cohort provides the characteristic seizure pattern.

👪

Inheritance

1

Autosomal dominant HP:0000006

BFIE is inherited in an autosomal dominant pattern with high but not complete penetrance. PRRT2, SCN2A, SCN8A, and ANKH variants segregate vertically across multiple generations in reported pedigrees.

Autosomal dominant inheritance

Show evidence (2 references)

PMID:22243967 SUPPORT Human Clinical

"Benign familial infantile epilepsy (BFIE) is a self-limited seizure disorder that occurs in infancy and has autosomal-dominant inheritance."

The PRRT2 discovery paper explicitly defines BFIE as an autosomal-dominant infantile seizure disorder.

PMID:29334453 SUPPORT Other

"Reduced penetrance and variable expressivity are commonly observed, leading to considerable phenotypic variability among heterozygous family members. Each child of an individual with a heterozygous PRRT2 pathogenic variant has a 50% chance of inheriting the pathogenic variant."

GeneReviews defines both reduced penetrance and the 50% recurrence risk for the major molecular subtype.

◆

Subtypes

4

Infantile Convulsions with Choreoathetosis MONDO:0011178

Combined familial syndrome in which infantile seizures (BFIE) and an adolescent-onset movement disorder (paroxysmal kinesigenic choreoathetosis) co-occur in the same individual or within the same family. Caused by PRRT2 variants, with very high mutation detection rates (>90%).

Show evidence (1 reference)

PMID:22243967 SUPPORT Human Clinical

"We also report PRRT2 mutations in five of six (83%) families affected by infantile convulsions and choreoathetosis (ICCA) syndrome, a familial syndrome in which infantile seizures and an adolescent-onset movement disorder, paroxysmal kinesigenic choreoathetosis (PKC), co-occur."

The discovery study directly supports the PRRT2-related combined seizure and movement-disorder subtype.

?

Discussions and Knowledge Gaps

3

What determines whether a single PRRT2 loss-of-function allele (classically c.649dupC) manifests as infantile epilepsy (BFIE), later paroxysmal kinesigenic dyskinesia (PKD), the combined ICCA phenotype, or hemiplegic migraine, sometimes varying even among carriers within one family?

KNOWLEDGE GAP OPEN gap_prrt2_pleiotropy_phenotype_determinant

Attached to

pathophysiology#Pleiotropic PRRT2 Effects Across Cortex and Basal Ganglia pathophysiology#PRRT2 Loss-of-Function and Impaired Synaptic Vesicle Release

The same recurrent truncating PRRT2 allele predicted to cause haploinsufficiency produces phenotypes that differ in age of expression (infancy versus later childhood) and anatomical substrate (cortex versus basal ganglia). Because the primary lesion is shared, the factors selecting among BFIE, PKD, ICCA, and migraine (genetic modifiers, developmental timing of PRRT2-dependent release in different circuits, environmental triggers) remain a genuine mechanistic gap that curation cannot resolve from the single-gene defect alone.

Proposed experiments

PRRT2 knock-in allelic-series circuit-timing experiment

developmental circuit electrophysiology experiment

exp_prrt2_knockin_allelic_circuit_timing

Introduce the recurrent c.649dupC and other truncating PRRT2 alleles on defined genetic backgrounds and profile, across postnatal development, calcium-dependent synchronous release and network excitability separately in cortical and striatal circuits to test whether region-specific and age-specific release deficits predict the cortical-seizure versus basal-ganglia-dyskinesia phenotype.

Perturbations

PRRT2 truncating allele knock-in

pathophysiology#PRRT2 Loss-of-Function and Impaired Synaptic Vesicle Release

Knock-in of c.649dupC and additional truncating alleles compared against matched wild-type controls.

PRRT2 hgnc:30500

Readouts

Region-specific synchronous release and excitability

pathophysiology#Pleiotropic PRRT2 Effects Across Cortex and Basal Ganglia

neurotransmitter secretion GO:0007269 ↓ DECREASED synaptic vesicle exocytosis GO:0016079 ↓ DECREASED

multielectrode array recording patch-clamp electrophysiology

Direction: NEGATIVE

Controls

Wild-type littermates

Matched wild-type animals profiled at the same developmental ages.

Decision criterion

A circuit-timing model of pleiotropy is supported if release and excitability deficits are cortex-predominant during infancy and shift toward the basal ganglia at ages matching PKD onset.

Would support

pathophysiology#Pleiotropic PRRT2 Effects Across Cortex and Basal Ganglia

Show evidence (2 references)

PMID:22243967 SUPPORT Human Clinical

"PRRT2 mutations elicit pleiotropy in terms of both age of expression (infancy versus later childhood) and anatomical substrate (cortex versus basal ganglia)."

Documents the age-dependent and region-dependent pleiotropy whose determinants are the open question.

PMID:23343561 SUPPORT Other

"The vast majority of these mutations are truncating and are predicted to lead to haploinsufficiency."

Establishes that a shared haploinsufficiency mechanism underlies the divergent phenotypes, so phenotype selection must be governed by factors beyond the primary allele.

Why do PRRT2-related infantile seizures remit spontaneously by the second year while the same haploinsufficient allele can produce persistent paroxysmal kinesigenic dyskinesia later in the same individuals?

OPEN QUESTION OPEN gap_bfie_spontaneous_remission_developmental_window

Attached to

pathophysiology#PRRT2 Loss-of-Function and Impaired Synaptic Vesicle Release

The self-limiting course of the seizure phenotype is a defining and clinically reassuring feature of BFIE, yet its mechanistic basis is unexplained. Because PRRT2 haploinsufficiency persists lifelong, remission implies a developmental-window process (maturation of inhibitory circuits, compensatory presynaptic release proteins, or age-dependent PRRT2 requirement) that resolves cortical hyperexcitability without correcting the genetic lesion, in contrast to the later-emerging and persistent movement disorder in the same carriers.

Proposed experiments

BFIE developmental excitability time-course experiment

longitudinal developmental profiling experiment

exp_bfie_developmental_excitability_timecourse

In a PRRT2-haploinsufficient model, quantify cortical network excitability, inhibitory-circuit maturation, and expression of candidate compensatory presynaptic release proteins across the infantile seizure-prone window and after the expected remission age to test whether remission tracks with maturation-driven normalization of synchronous release rather than with any change in PRRT2 dosage.

Perturbations

PRRT2 haploinsufficiency

pathophysiology#PRRT2 Loss-of-Function and Impaired Synaptic Vesicle Release

PRRT2 loss-of-function background profiled longitudinally against wild-type controls.

PRRT2 hgnc:30500

Readouts

Excitability normalization over development

pathophysiology#PRRT2 Loss-of-Function and Impaired Synaptic Vesicle Release

synaptic vesicle exocytosis GO:0016079 ↓ DECREASED trans-synaptic signaling GO:0099537 ↕ DYSREGULATED

multielectrode array recording

Direction: NEGATIVE

Controls

Wild-type developmental controls

Matched wild-type samples profiled at the same ages.

Decision criterion

A developmental-window model of remission is supported if network hyperexcitability and synchronous-release deficits normalize by the post-remission age despite unchanged PRRT2 dosage.

Would support

pathophysiology#PRRT2 Loss-of-Function and Impaired Synaptic Vesicle Release

Show evidence (2 references)

PMID:22243967 SUPPORT Human Clinical

"Benign familial infantile epilepsy (BFIE) is a self-limited seizure disorder that occurs in infancy and has autosomal-dominant inheritance."

Establishes the self-limited seizure course whose developmental basis is the open question.

PMID:38160512 SUPPORT Human Clinical

"Paroxysmal kinesiogenic dyskinesia (n=5) occurred in 4 families and hemiplegic migraine (n=8) in 3 families."

Documents the later-onset persistent PKD phenotype in the same families, contrasting with the transient seizure phase and framing the window-specific remission question.

Do the presynaptic-release route (PRRT2), the voltage-gated sodium-channel routes (SCN2A and SCN8A), and the unresolved ANKH route to self-limited familial infantile epilepsy converge on a single infantile hyperexcitability mechanism, or represent distinct pathways with a common clinical endpoint?

KNOWLEDGE GAP OPEN gap_bfie_synaptic_vs_channel_convergence

Attached to

pathophysiology#PRRT2 Loss-of-Function and Impaired Synaptic Vesicle Release pathophysiology#SCN2A Nav1.2 Variant-Specific Excitability pathophysiology#SCN8A Nav1.6 Familial Epilepsy Association pathophysiology#ANKH Start-Region Variant With Unresolved Epilepsy Mechanism

BFIE is genetically heterogeneous, arising from a presynaptic release-machinery protein (PRRT2) and from ion-channel subunits (SCN2A, SCN8A), with a rare ANKH association whose neuronal mechanism remains unknown. Whether these lesions converge on a common infantile cortical hyperexcitability node, or produce the same self-limited phenotype by parallel routes, is unresolved and bears on whether the syndrome should be modeled as one mechanism with substitutable drivers or several convergent mechanisms.

Proposed experiments

BFIE multi-gene convergence electrophysiology screen

comparative network electrophysiology screen

exp_bfie_multigene_convergence_screen

In a shared infantile cortical-network assay, compare PRRT2 loss, familial SCN2A and SCN8A alleles, and ANKH c.-11C>T for a common signature of increased network synchrony and excitatory/inhibitory imbalance, testing whether the distinct molecular lesions converge on one hyperexcitability node.

Perturbations

PRRT2 c.649dupC loss-of-function knock-in

pathophysiology#PRRT2 Loss-of-Function and Impaired Synaptic Vesicle Release

Introduce the recurrent PRRT2 c.649dupC loss-of-function allele in the shared assay background.

PRRT2 hgnc:30500

Familial SCN2A L1563V knock-in

pathophysiology#SCN2A Nav1.2 Variant-Specific Excitability

Introduce the familial SCN2A L1563V allele in the same assay background.

SCN2A hgnc:10588

Familial SCN8A p.E1483K knock-in

pathophysiology#SCN8A Nav1.6 Familial Epilepsy Association

Introduce the recurrent familial SCN8A p.E1483K allele in the same assay background.

SCN8A hgnc:10596

ANKH c.-11C>T start-region knock-in

pathophysiology#ANKH Start-Region Variant With Unresolved Epilepsy Mechanism

Introduce the recurrent ANKH c.-11C>T start-region allele in the same assay background.

ANKH hgnc:15492

Readouts

Shared network hyperexcitability signature

epilepsy_excitation_inhibition_imbalance:pathophysiology#Neuronal Hyperexcitability and Hypersynchrony

regulation of membrane potential GO:0042391 ↕ DYSREGULATED neuronal action potential GO:0019228 ↑ INCREASED

multielectrode array recording

Direction: POSITIVE

Interpretation: Compare network synchrony, firing, and excitability profiles across all four isogenic perturbations. A genuinely shared signature supports convergence on the conserved epilepsy hyperexcitability node; distinct signatures support parallel routes to the same clinical endpoint.

Controls

Wild-type background

Unperturbed matched networks.

Decision criterion

Convergence is supported if the distinct BFIE-gene perturbations reproducibly produce the same network hyperexcitability signature; parallel routes are supported if their signatures differ despite a shared clinical endpoint.

Would support

epilepsy_excitation_inhibition_imbalance:pathophysiology#Neuronal Hyperexcitability and Hypersynchrony

Show evidence (2 references)

PMID:12243921 SUPPORT Human Clinical

"Here, we describe a clinically intermediate variant, benign familial neonatal-infantile seizures, with mutations in the sodium-channel subunit gene SCN2A."

Documents the sodium-channel route to benign familial infantile-onset seizures, distinct from the PRRT2 presynaptic route.

PMID:27052163 SUPPORT In Vitro

"PRRT2 interacts with the synaptic proteins SNAP-25 and synaptotagmin 1/2."

Places PRRT2 in the presynaptic release machinery, defining the mechanistic route that must be reconciled with the ion-channel routes.

⚙

Pathophysiology

6

PRRT2 Loss-of-Function and Impaired Synaptic Vesicle Release

PRRT2 encodes a presynaptic, transmembrane-anchored protein that interacts with SNAP-25 and synaptotagmin 1/2 and contributes to the calcium-dependent neurotransmitter release machinery. Heterozygous truncating PRRT2 variants cause haploinsufficiency in presynaptic terminals, impairing synchronous neurotransmitter release and altering cortical and basal-ganglia network excitability. This presynaptic defect is the leading mechanistic model for the shared pathogenesis of BFIE, ICCA, and PKD.

neuron CL:0000540

PRRT2 hgnc:30500

neurotransmitter secretion GO:0007269 ↓ DECREASED synaptic vesicle exocytosis GO:0016079 ↓ DECREASED

brain UBERON:0000955 cerebral cortex UBERON:0000956 striatum UBERON:0002435

Experimental models

PRRT2-null primary mouse hippocampal neuron model PRIMARY CELL CULTURE Autaptic PRRT2-null neurons model impaired Cav2.1 targeting and calcium-dependent glutamatergic release.

Downstream

PRRT2-Deficient Network Hyperexcitability Altered excitatory and inhibitory synaptic transmission after PRRT2 loss destabilizes neuronal networks and produces heightened spontaneous and evoked activity.

Show evidence (5 references)

PMID:23343561 SUPPORT Other

"PRRT2 is a largely uncharacterised protein. It is expressed in the brain and has been demonstrated to interact with SNAP-25, a component of the molecular machinery involved in the release of neurotransmitters at the presynaptic membrane."

Review summarizing prior in vitro biochemical work establishing PRRT2 presynaptic localization and SNAP-25 interaction.

PMID:27052163 SUPPORT In Vitro

"We show that PRRT2 is enriched in presynaptic terminals and that its silencing decreases the number of synapses and increases the number of docked synaptic vesicles at rest."

Direct cellular evidence that PRRT2 loss perturbs synaptic vesicle pools.

PMID:27052163 SUPPORT In Vitro

"PRRT2-silenced neurons exhibit a severe impairment of synchronous release, attributable to a sharp decrease in release probability and Ca(2+) sensitivity and associated with a marked increase of the asynchronous/synchronous release ratio."

Loss of PRRT2 specifically impairs calcium-dependent synchronous neurotransmitter release.

+ 2 more references

PRRT2-Deficient Network Hyperexcitability

PRRT2 loss changes short-term synaptic plasticity in both excitatory and inhibitory neurons. The net effect in primary hippocampal cultures and acute slices is unstable, hyperexcitable network activity, providing an experimentally observed bridge between the presynaptic lesion and seizures.

glutamatergic neuron CL:0000679 GABAergic neuron CL:0000617 hippocampal neuron CL:0002608

PRRT2 hgnc:30500

chemical synaptic transmission GO:0007268 ↕ DYSREGULATED regulation of membrane potential GO:0042391 ↕ DYSREGULATED

hippocampal formation UBERON:0002421

Experimental models

PRRT2-null primary mouse hippocampal neuron model PRIMARY CELL CULTURE The model measures the net network consequence of altered excitatory and inhibitory transmission after PRRT2 loss.

Downstream

Focal-Onset Infantile Seizures Hyperexcitable neuronal networks predispose infants with PRRT2 loss to focal-onset seizures.

Seizure Clusters Network instability manifests clinically as recurrent clusters of brief infantile seizures.

Focal-to-Bilateral Tonic-Clonic Seizures Focal network seizures can spread bilaterally to tonic-clonic activity.

Show evidence (1 reference)

PMID:29912316 SUPPORT In Vitro

"The data indicate the existence of network instability/hyperexcitability as the possible basis of the paroxysmal phenotypes associated with PRRT2 mutations."

The experimental study identifies network hyperexcitability as the likely basis of PRRT2 paroxysmal phenotypes.

Pleiotropic PRRT2 Effects Across Cortex and Basal Ganglia

PRRT2 mutations exhibit anatomical and temporal pleiotropy: the same haploinsufficient allele produces cortical infantile seizures (BFIE) early in life and basal-ganglia paroxysmal kinesigenic dyskinesia (PKD) later in childhood or adolescence. ICCA represents the co-expression of both phenotypes within an individual or family.

PRRT2 hgnc:30500

cerebral cortex UBERON:0000956 striatum UBERON:0002435

Downstream

Paroxysmal Kinesigenic Dyskinesia PRRT2 loss-of-function produces adolescent-onset paroxysmal kinesigenic dyskinesia in a subset of carriers, defining the ICCA syndrome when combined with infantile seizures.

Show evidence (1 reference)

PMID:22243967 SUPPORT Human Clinical

"PRRT2 mutations elicit pleiotropy in terms of both age of expression (infancy versus later childhood) and anatomical substrate (cortex versus basal ganglia)."

Directly supports the pleiotropy mechanism distinguishing BFIE from PKD within the same gene.

SCN2A Nav1.2 Variant-Specific Excitability

Heterozygous SCN2A variants can produce mild familial neonatal-infantile seizures or severe developmental and epileptic encephalopathy. Functional effects and clinical consequences are variant-specific; dynamic action-potential clamp distinguishes the familial L1563V allele from severe de novo alleles without supporting a single direction of effect for every SCN2A-associated epilepsy.

neuron CL:0000540

SCN2A hgnc:10588

neuronal action potential GO:0019228 ↕ DYSREGULATED

cerebral cortex UBERON:0000956

Downstream

Focal-Onset Infantile Seizures Familial SCN2A variants can produce self-limited neonatal-infantile focal seizures.

Show evidence (1 reference)

PMID:29844171 SUPPORT In Vitro

"Overall, the study shows a strong correlation between clinical phenotype, SCN2A genotype, and functional modeling."

Electrophysiologic modeling supports variant-specific Nav1.2 dysfunction rather than an unqualified gene-wide mechanism.

SCN8A Nav1.6 Familial Epilepsy Association

The recurrent SCN8A p.E1483K allele cosegregates with a mild familial infantile seizure and dyskinesia phenotype. SCN8A encodes a voltage-gated sodium channel, but the precise functional direction of this familial allele is not asserted here because the cited family study is clinical.

SCN8A hgnc:10596

neuronal action potential GO:0019228 ↕ DYSREGULATED

Downstream

Focal-Onset Infantile Seizures The familial SCN8A allele is associated with afebrile focal seizures in infancy.

Show evidence (1 reference)

PMID:26677014 SUPPORT Human Clinical

"Fifteen affected members presented with afebrile focal or generalized tonic-clonic seizures during the first to second year of life; 5 of them experienced single unprovoked seizures later on."

Three-family phenotyping establishes the mild infantile seizure phenotype of the recurrent SCN8A allele.

ANKH Start-Region Variant With Unresolved Epilepsy Mechanism

The recurrent ANKH c.-11C>T start-region variant segregates with self-limited familial infantile epilepsy in two families, but its molecular effect in neurons and the pathway from ANKH dysfunction to seizures remain unresolved.

ANKH hgnc:15492

Downstream

Focal-Onset Infantile Seizures The ANKH variant is genetically associated with focal and bilateral tonic-clonic infantile seizures, but the intervening mechanism is unknown.

Show evidence (1 reference)

PMID:40574727 SUPPORT Human Clinical

"To our knowledge, we report the second family with autosomal dominant epilepsy caused by an ANKH c.-11C>T variant."

Recurrence and segregation support causation while leaving the neuronal mechanism open.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

4

Nervous System 2

Focal-Onset Infantile Seizures Focal-onset seizure HP:0007359

Show evidence (2 references)

PMID:22243967 SUPPORT Human Clinical

"Benign familial infantile epilepsy (BFIE) is a self-limited seizure disorder that occurs in infancy and has autosomal-dominant inheritance."

The discovery paper defines BFIE clinically as a self-limited infantile seizure disorder.

PMID:37170076 SUPPORT Human Clinical

"Ten infants presented with focal seizures at a median age of 5 months (range: 3-6 months)."

A genetically confirmed PRRT2 cohort supplies seizure type and typical onset timing.

Seizure Clusters HP:0001250

Temporal: RECURRENT

Show evidence (2 references)

PMID:23077018 SUPPORT Human Clinical

"Benign familial infantile epilepsy (BFIE) is an autosomal dominant epilepsy syndrome characterized by afebrile seizures beginning at about 6 months of age."

Defines BFIE clinically as an autosomal dominant afebrile infantile-seizure syndrome.

PMID:31901402 SUPPORT Human Clinical

"The mean cluster duration was 2.9 days (range 1-13) (see Table 1). Twelve infants had only one cluster."

The infant cohort quantifies cluster duration and shows that a single cluster can occur.

Other 2

Focal-to-Bilateral Tonic-Clonic Seizures Bilateral tonic-clonic seizure with focal onset HP:0007334

Show evidence (1 reference)

PMID:31901402 SUPPORT Human Clinical

"All patients had focal motor or non-motor seizures, in 12 (52%) followed by bilateral (tonic)clonic seizures."

The cohort directly documents focal-to-bilateral seizure evolution.

Paroxysmal Kinesigenic Dyskinesia Paroxysmal dyskinesia HP:0007166

Show evidence (1 reference)

PMID:22243967 SUPPORT Human Clinical

"We also report PRRT2 mutations in five of six (83%) families affected by infantile convulsions and choreoathetosis (ICCA) syndrome, a familial syndrome in which infantile seizures and an adolescent-onset movement disorder, paroxysmal kinesigenic choreoathetosis (PKC), co-occur."

The PRRT2 discovery paper directly links PRRT2-related BFIE/ICCA families to adolescent-onset paroxysmal kinesigenic choreoathetosis, supporting the local paroxysmal dyskinesia phenotype and resolving the existing pathograph target.

🧬

Genetic Associations

4

PRRT2 (Causal loss-of-function variant)

Gene: PRRT2 hgnc:30500

Show evidence (3 references)

PMID:22243967 SUPPORT Human Clinical

"We have identified heterozygous mutations in PRRT2, which encodes proline-rich transmembrane protein 2, in 14 of 17 families (82%) affected by BFIE, indicating that PRRT2 mutations are the most frequent cause of this disorder."

This is the discovery paper establishing PRRT2 as the major BFIE gene.

PMID:23077018 SUPPORT Human Clinical

"PRRT2 mutations are present in >80% of BFIE and >90% ICCA families, but are not a common cause of other forms of infantile epilepsy."

Independent replication of PRRT2 mutation frequency in BFIE and ICCA cohorts.

PMID:23343561 SUPPORT Other

"The vast majority of these mutations are truncating and are predicted to lead to haploinsufficiency."

Reviews the haploinsufficiency mechanism that unifies PRRT2-related BFIE, ICCA, and PKD.

SCN2A (Causal variant)

Gene: SCN2A hgnc:10588

Show evidence (2 references)

PMID:12243921 SUPPORT Human Clinical

"Here, we describe a clinically intermediate variant, benign familial neonatal-infantile seizures, with mutations in the sodium-channel subunit gene SCN2A."

Original identification of SCN2A as the gene underlying benign familial neonatal-infantile seizures.

PMID:29844171 SUPPORT In Vitro

"Dynamic clamp was also able to functionally separate the L1563V variant, seen in benign familial neonatal-infantile seizures from R1882Q, seen in DEE, suggesting a diagnostic potential for this type of analysis."

Functional modeling shows that a familial SCN2A allele differs from a severe de novo encephalopathy allele.

SCN8A (Causal variant (mild end of SCN8A spectrum))

Gene: SCN8A hgnc:10596

Show evidence (1 reference)

PMID:26677014 SUPPORT Human Clinical

"In 3 families with a total of 16 affected members, we identified the same, cosegregating heterozygous missense mutation (c.4447G>A; p.E1483K) in SCN8A, encoding a voltage-gated sodium channel."

A recurrent cosegregating SCN8A allele directly supports familial causation.

ANKH (Causal recurrent start-region variant)

Gene: ANKH hgnc:15492

Show evidence (1 reference)

PMID:40574727 SUPPORT Human Clinical

"Short-read genome/exome sequencing and comparative bioinformatic analysis of the variants of five affected individuals and one unaffected individual revealed ANKH c.-11C>T as the causative pathogenic variant in this family, segregating with the disease."

Segregation in a second reported family supports the recurrent ANKH start-region variant as a rare cause.

💊

Medical Actions

2

Sodium-Channel-Blocking Antiseizure Medication

Action: anticonvulsant agent therapy Ontology label: Anticonvulsant Therapy NCIT:C64172

Agent: carbamazepine CHEBI:3387 oxcarbazepine CHEBI:7824

Carbamazepine or oxcarbazepine is often highly effective for acute seizure clusters in PRRT2-associated self-limited infantile epilepsy. Evidence is retrospective and observational rather than randomized, and treatment duration should be individualized in view of spontaneous remission.

Target Phenotypes: Focal-onset seizure HP:0007359 Bilateral tonic-clonic seizure with focal onset HP:0007334

Show evidence (3 references)

PMID:36187725 SUPPORT Human Clinical

"Sodium channel blockers were used in 22 individuals and resulted in seizure freedom in all but 1 child, who showed a reduction of more than 50% in seizure frequency."

The largest treatment-response cohort directly supports high response to sodium-channel blockers.

PMID:36187725 SUPPORT Human Clinical

"This study provides Class IV evidence that in individuals with PRRT2-associated infantile epilepsy, sodium channel blockers are associated with reduced seizure frequency but levetiracetam is not."

The authors' evidence classification makes the observational limitation explicit.

PMID:40401013 SUPPORT Human Clinical

"Thirty-seven children (n = 37/40, 93%) were treated with antiseizure medications, and sodium channel blockers were effective in most (20/27 responded, 74%)."

A recent international cohort independently supports frequent response while showing that it is not universal.

Supportive Management and Surveillance

Action: supportive care Ontology label: Supportive Care NCIT:C15747

GeneReviews advises prompt fever treatment during the self-limited familial infantile epilepsy phase and regularly scheduled follow-up to monitor existing manifestations, response to supportive care, and emergence of new manifestations. This is supportive-care guidance, not evidence for a specific antiseizure medication.

Show evidence (1 reference)

PMID:29334453 SUPPORT Other

"Surveillance: Monitoring existing manifestations, the individual's response to supportive care, and the emergence of new manifestations requires regularly scheduled follow up with the treating neurologist as well as educators and social services. Agents/circumstances to avoid: For self-limited..."

GeneReviews supplies separate supportive-care and surveillance guidance without asserting efficacy for a particular antiseizure medication.

🔬

Diagnosis

2

Electroclinical recognition with interictal and peri-ictal EEG (SUPPORTIVE)

Diagnosis begins with the characteristic age, brief afebrile focal seizures in clusters, normal development, and compatible family history. The interictal EEG is usually normal; an EEG obtained within 24 hours of a seizure can show bilateral temporo-occipital focal epileptiform discharges. A normal interictal study therefore does not exclude the syndrome.

electroencephalography NCIT:C38054

Show evidence (2 references)

PMID:37170076 SUPPORT Human Clinical

"Pathogenic PRRT2 variants cause self-limited (familial) infantile epilepsy (SeLIE), which is responsive to sodium channel blocking antiseizure medications. The interictal EEG is typically normal."

The EEG cohort explicitly establishes the usual interictal pattern.

PMID:37170076 SUPPORT Human Clinical

"Seven of the eight infants with an EEG performed within 24 h of the most recent seizure had epileptiform discharges."

Timing-dependent peri-ictal abnormalities explain why an otherwise normal interictal EEG can coexist with the syndrome.

Molecular genetic testing for etiologic assignment (RECOMMENDED_FOR_ETIOLOGIC_ASSIGNMENT)

Sequence and copy-number analysis should prioritize PRRT2 and include SCN2A and SCN8A; ANKH c.-11C>T is a rare consideration, especially when joint pain or chondrocalcinosis segregates in the family. Broad testing is appropriate for atypical, refractory, developmentally concerning, or PRRT2-negative presentations.

genetic testing NCIT:C15709

Show evidence (2 references)

PMID:29334453 SUPPORT Other

"The diagnosis of PRRT2-related disorder is established in a proband with suggestive findings and a heterozygous PRRT2 pathogenic variant identified by molecular genetic testing."

GeneReviews directly supports molecular confirmation for PRRT2-related disease.

PMID:40574727 SUPPORT Human Clinical

"ANKH-associated epilepsy should be considered in SeLFIE, especially in cases with a family history of chondrocalcinosis or recurrent acute joint pain episodes."

The recurrent-family report supplies a specific clue for extending testing to ANKH.

📈

Progression

4

Seizure clusters in infancy

Age: 3-12 months (typical)

Affected infants present with clusters of focal-onset seizures, often within a single day or over several days, on a background of normal development and neurological examination. Interictal EEG is characteristically normal.

Show evidence (1 reference)

PMID:23077018 SUPPORT Human Clinical

"Benign familial infantile epilepsy (BFIE) is an autosomal dominant epilepsy syndrome characterized by afebrile seizures beginning at about 6 months of age."

Supports the infantile-onset seizure phase centered on ~6 months.

Spontaneous remission

Age: infancy to early childhood

Seizure freedom is usually reached during infancy or by the end of the second year. Persistence beyond age 2 years, frequent recurrence, or treatment resistance should prompt reassessment for another genetic epilepsy; the reported ANKH families can remit somewhat later.

Show evidence (2 references)

PMID:31901402 SUPPORT Human Clinical

"When clusters reoccur frequently, when seizures are more therapy-resistant and when seizures persist beyond the age of 2 years, another diagnosis or causative gene is likely."

The cohort bounds the expected self-limited window and identifies red flags for diagnostic reassessment.

PMID:40574727 SUPPORT Human Clinical

"Patients responded well to antiseizure medication, and seizures resolved completely before the age of 4 years."

The rare ANKH subtype demonstrates a still self-limited but somewhat broader remission window.

Later seizure recurrence or episodic PRRT2 manifestations

Age: childhood to adulthood

A minority have later isolated seizures. PRRT2 carriers can develop paroxysmal kinesigenic dyskinesia or migraine after the infantile epilepsy has remitted; these later manifestations reflect pleiotropy rather than persistence of the infantile syndrome.

Show evidence (2 references)

PMID:38160512 SUPPORT Human Clinical

"Ten of 50 individuals (20%) had seizure recurrence, aged 8-65 years. Median time from last neonatal/infantile seizure was 11.8/12.8 years."

The mixed familial neonatal/infantile cohort quantifies a non-zero risk of later seizure recurrence.

PMID:38160512 SUPPORT Human Clinical

"Paroxysmal kinesiogenic dyskinesia (n=5) occurred in 4 families and hemiplegic migraine (n=8) in 3 families."

The long-term cohort documents later episodic movement and migraine phenotypes.

Long-term outcome

Most individuals achieve normal cognitive and adaptive functioning, though a minority show mild neurodevelopmental concerns, particularly when seizure burden in infancy was high or treatment duration was prolonged.

Show evidence (2 references)

PMID:38160512 SUPPORT Human Clinical

"Vineland-3 identified 3 had low-average and 3 had mild-moderately impaired functioning. The majority (82%) were average."

Adaptive function outcomes support generally favorable long-term outcome with a minority showing mild impairment.

PMID:24958006 SUPPORT Human Clinical

"Fine motor and gross motor skills, language, adaptive personal/social skills were near-normal in all patients with self-limited familial infantile epilepsy."

A separate cohort supports generally favorable development in the familial subgroup.

🔀

Differential Diagnoses

2

Conditions with similar clinical presentations that must be differentiated from Benign Familial Infantile Epilepsy:

Self-limited familial neonatal epilepsy MONDO:0016027

Overlapping Features Both disorders are autosomal dominant and self-limited. Predominantly neonatal onset and a KCNQ2/KCNQ3 molecular diagnosis favor familial neonatal epilepsy; onset later in infancy, clustering, and PRRT2 favor the focal disease curated here. SCN2A-associated neonatal-infantile epilepsy bridges the age boundary and is retained as an overlapping subtype.

Distinguishing Features

Seizure onset predominantly in the neonatal period
KCNQ2 or KCNQ3 pathogenic variant

Show evidence (1 reference)

PMID:12243921 SUPPORT Human Clinical

"Two autosomal dominant disorders present in the first year of life: benign familial neonatal seizures, which is associated with potassium-channel gene defects; and benign familial infantile seizures, for which no genes have been identified."

The original SCN2A study explicitly separates neonatal and infantile familial syndromes while defining the intermediate form.

📊

Related Datasets

1

Neurodevelopmental outcomes in a cohort of Australian families with self-limited familial epilepsy of neonatal/infantile onset. PMID:38160512

Australian multigenerational cohort of 15 families and 73 affected individuals with self-limited familial neonatal/infantile epilepsy; 50 participants underwent in-depth phenotyping and adaptive-function assessment. The cohort spans PRRT2, KCNQ2, SCN2A, and SCN8A and is therefore broader than the focal infantile entity.

human n=73

Conditions: self-limited familial epilepsy of neonatal/infantile onset

PMID:38160512

Show evidence (1 reference)

PMID:38160512 SUPPORT Human Clinical

"Fifteen families participated. Fourteen had a genetic diagnosis (93%): 11 pathogenic; PRRT2 (n=4), KCNQ2 (n=3), SCN2A (n=4), 3 likely pathogenic; KCNQ2 (n=1), SCN8A (n=2). Seizures affected 73 individuals (ages 1-76 years); 30 children and 20 adults had in-depth phenotyping."

The publication defines the cohort size, molecular composition, and deeply phenotyped subset.

🔬

Clinical Trials

2

NCT06585605 NOT_APPLICABLE RECRUITING

Multinational retrospective observational survey of epilepsy-dyskinesia syndromes, including genetic causes such as PRRT2, SCN2A, and SCN8A. It is relevant to ICCA and related familial overlap phenotypes but requires a pediatric movement disorder and is not a BFIE treatment trial.

Target Phenotypes: Seizure HP:0001250 Paroxysmal dyskinesia HP:0007166

Show evidence (1 reference)

clinicaltrials:NCT06585605 SUPPORT Human Clinical

"The Epilepsy-Dyskinesia Study aims to advance the understanding of the clinical and molecular spectrum of epilepsy-dyskinesia syndromes, monogenic diseases that cause both movement disorders and epilepsy."

The registry summary establishes its combined epilepsy and dyskinesia scope.

NCT06967727 NOT_APPLICABLE RECRUITING

Prospective registry and natural-history study collecting longitudinal clinical data and biospecimens from genetically diagnosed epilepsy-dyskinesia syndromes, including PRRT2-, SCN2A-, and SCN8A-related disease. It is broader than self-limited familial infantile epilepsy.

Target Phenotypes: Seizure HP:0001250 Paroxysmal dyskinesia HP:0007166

Show evidence (1 reference)

clinicaltrials:NCT06967727 SUPPORT Human Clinical

"The Registry and Natural History of Epilepsy-Dyskinesia Syndromes is focused on gathering longitudinal clinical data as well as biological samples (blood, urine, and/or skin/tissue) from male and female patients, of all ages, who have a genetic diagnosis of epilepsy-dyskinesia syndromes."

The registry summary directly defines the longitudinal and biospecimen collection.

🧫

Experimental Models

1

PRRT2-null primary mouse hippocampal neuron model PRIMARY_CELL_CULTURE

Primary Prrt2-null hippocampal neurons and related acute slices reproduce altered excitatory and inhibitory synaptic dynamics, network hyperexcitability, and defective P/Q-type calcium-channel targeting.

Organism

mouse NCBITaxon:10090

Tissue

hippocampal formation UBERON:0002421

Cell source

Primary hippocampal neurons isolated from embryos carrying a constitutively inactivated Prrt2 gene

Culture

Primary neuronal cultures, autaptic cultures, and acute hippocampal slices

Publication

PMID:29912316

Pathograph links

PRRT2-Deficient Network Hyperexcitability The model measures the net network consequence of altered excitatory and inhibitory transmission after PRRT2 loss.

Show evidence (1 reference)

PMID:29912316 SUPPORT In Vitro

"At the network level these complex synaptic effects resulted in a state of heightened spontaneous and evoked activity that was associated with increased excitability of excitatory neurons in both PRRT2 knockout primary cultures and acute hippocampal slices."

Primary cultures and acute slices directly reproduce the curated hyperexcitability mechanism.

PRRT2 Loss-of-Function and Impaired Synaptic Vesicle Release Autaptic PRRT2-null neurons model impaired Cav2.1 targeting and calcium-dependent glutamatergic release.

Show evidence (1 reference)

PMID:34133925 SUPPORT In Vitro

"The data highlight the central role of PRRT2 in ensuring the physiological Ca2+ sensitivity of the release machinery at glutamatergic synapses."

The culture study directly supports the presynaptic calcium-sensitivity mechanism.

Show evidence (1 reference)

PMID:29912316 SUPPORT In Vitro

"In this work, we investigated the phenotype of primary hippocampal neurons obtained from mouse embryos in which the PRRT2 gene was constitutively inactivated."

The publication explicitly defines the primary-neuron model and genetic perturbation.

🐁

Animal Models

2

Constitutive Prrt2 knockout Mus musculus Neurological

Constitutive Prrt2-null mice model PRRT2 deficiency. They show paroxysmal movements, abnormal audiogenic motor behavior, increased sensitivity to pentylenetetrazole-induced convulsions, and cerebellar synaptic changes. Adult provoked-convulsion susceptibility is supportive but does not exactly reproduce the spontaneous infantile human seizure window.

Species

Mus musculus

Genotype

Constitutive Prrt2 knockout

Background

C57BL

Genes

Prrt2 MGI:1916267

Show evidence (1 reference)

PMID:28007585 SUPPORT Model Organism

"In addition, adult PRRT2 KO mice present abnormal motor behaviors characterized by wild running and jumping in response to audiogenic stimuli that are ineffective in wild type mice and an increased sensitivity to the convulsive effects of pentylentetrazol."

The knockout model directly demonstrates paroxysmal behavior and increased provoked-convulsion sensitivity.

Heterozygous and homozygous Prrt2 knockout allelic series Mus musculus Neurological

Heterozygous and homozygous Prrt2 knockout mice provide an allelic series for developmental timing. Synaptic-protein changes are strongest early postnatally and attenuate with age, while motor phenotypes occupy a later window. The study models age dependence but does not prove the mechanism of human infantile seizure remission.

Species

Mus musculus

Genotype

Heterozygous and homozygous Prrt2 knockout allelic series

Genes

Prrt2 MGI:1916267

Show evidence (1 reference)

PMID:34101060 SUPPORT Model Organism

"We show that Prrt2 deletion reduces the levels of synaptic proteins in a dose-dependent manner that is most pronounced at postnatal day 5 (P5), attenuates at P60, and disappears by P180."

The allelic-series model directly demonstrates an age-dependent molecular phenotype.

{ }

Source YAML

click to show

name: Benign Familial Infantile Epilepsy
creation_date: "2026-05-13T12:00:00Z"
category: Mendelian
description: >-
  Self-limited familial infantile epilepsy (historically benign familial
  infantile epilepsy, BFIE) is an autosomal dominant epilepsy syndrome in which
  otherwise typically developing infants develop brief, afebrile focal or
  focal-to-bilateral tonic-clonic seizures, often in clusters. Onset is usually
  in the first year of life, interictal examination and EEG are usually normal,
  and seizures remit in early childhood. Heterozygous PRRT2 loss-of-function is
  the major cause and links the epilepsy to paroxysmal kinesigenic dyskinesia
  and the combined infantile convulsions and choreoathetosis syndrome. Rare
  familial phenocopies are associated with SCN2A, SCN8A, or the recurrent ANKH
  c.-11C>T variant. The favorable course is characteristic rather than
  absolute: later seizure recurrence and mild neurodevelopmental concerns occur
  in a minority.
disease_term:
  preferred_term: benign familial infantile epilepsy
  term:
    id: MONDO:0017615
    label: benign familial infantile epilepsy
synonyms:
- BFIE
- benign familial infantile seizures
- BFIS
- self-limited familial infantile epilepsy
parents:
- Epilepsy
classifications:
  harrisons_chapter:
  - classification_value: NEUROLOGIC
    evidence:
    - reference: PMID:29334453
      reference_title: PRRT2-Related Disorder.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        PRRT2-related disorder, caused by heterozygous pathogenic variants in
        the gene PRRT2 (associated with aberrant synaptic transmission), is
        characterized by three core episodic neurologic phenotypes: epilepsy,
        movement disorder, and migraine.
      explanation: The GeneReviews overview places the major molecular subtype within episodic neurologic disease.
definitions:
- name: Self-limited familial infantile epilepsy clinical definition
  definition_type: CASE_DEFINITION
  scope: Infants and families with a self-limited focal epilepsy beginning after the neonatal period
  description: >-
    A clinical syndrome of unprovoked focal seizures or focal-to-bilateral
    tonic-clonic seizures beginning in infancy, commonly in clusters, in a
    usually normally developing child with a compatible autosomal dominant
    family history and remission in early childhood. Molecular confirmation
    refines the subtype but is not required to recognize the electroclinical
    syndrome.
  evidence:
  - reference: PMID:31901402
    reference_title: The clinical and genetic spectrum in infants with (an) unprovoked cluster(s) of focal seizures.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Self-limited (familial) infantile epilepsy (S(F)IE), formerly known as
      benign (familial) infantile convulsions (B(F)IC), is an infantile cluster
      epilepsy with in rule a complete recovery.
    explanation: This cohort defines the syndrome using current terminology, infantile clustering, and recovery.
  - reference: PMID:36775847
    reference_title: "PRRT2-positive self-limited infantile epilepsy: Initial seizure characteristics and response to sodium channel blockers."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Patients with PRRT2-related epilepsy had characteristic seizure semiology
      at the initial presentation, including all afebrile, clustered
      (n = 23, 63.9%), short-duration (n = 33, 91.7%), and bilateral
      tonic-clonic seizures (n = 26, 72.2%).
    explanation: A genetically confirmed cohort provides the characteristic seizure pattern.
- name: PRRT2-related disorder molecular diagnosis
  definition_type: DIAGNOSTIC_CRITERIA
  scope: Individuals with a suggestive self-limited infantile epilepsy, movement-disorder, or migraine phenotype
  description: >-
    PRRT2-related disease is established by identifying a heterozygous
    pathogenic PRRT2 variant in an individual with suggestive findings.
  evidence:
  - reference: PMID:29334453
    reference_title: PRRT2-Related Disorder.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The diagnosis of PRRT2-related disorder is established in a proband with
      suggestive findings and a heterozygous PRRT2 pathogenic variant identified
      by molecular genetic testing.
    explanation: GeneReviews states the molecular diagnostic criterion for the major BFIE subtype.
has_subtypes:
- name: PRRT2-related BFIE
  subtype_term:
    preferred_term: seizures, benign familial infantile, 2
    term:
      id: MONDO:0011593
      label: seizures, benign familial infantile, 2
  description: >-
    The most frequent molecular subtype, accounting for >80% of BFIE families.
    Caused by heterozygous truncating PRRT2 variants leading to
    haploinsufficiency. Families may also include relatives with paroxysmal
    kinesigenic dyskinesia or infantile convulsions with choreoathetosis (ICCA).
  evidence:
  - reference: PMID:22243967
    reference_title: PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We have identified heterozygous mutations in PRRT2, which encodes
      proline-rich transmembrane protein 2, in 14 of 17 families (82%) affected
      by BFIE, indicating that PRRT2 mutations are the most frequent cause of
      this disorder.
    explanation: The discovery cohort establishes PRRT2-related BFIE as the major molecular subtype.
- name: ICCA
  display_name: Infantile Convulsions with Choreoathetosis
  subtype_term:
    preferred_term: infantile convulsions and choreoathetosis
    term:
      id: MONDO:0011178
      label: infantile convulsions and choreoathetosis
  description: >-
    Combined familial syndrome in which infantile seizures (BFIE) and an
    adolescent-onset movement disorder (paroxysmal kinesigenic choreoathetosis)
    co-occur in the same individual or within the same family. Caused by PRRT2
    variants, with very high mutation detection rates (>90%).
  evidence:
  - reference: PMID:22243967
    reference_title: PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We also report PRRT2 mutations in five of six (83%) families affected by
      infantile convulsions and choreoathetosis (ICCA) syndrome, a familial
      syndrome in which infantile seizures and an adolescent-onset movement
      disorder, paroxysmal kinesigenic choreoathetosis (PKC), co-occur.
    explanation: The discovery study directly supports the PRRT2-related combined seizure and movement-disorder subtype.
- name: SCN2A-related BFNIS
  display_name: SCN2A-related Benign Familial Neonatal-Infantile Seizures
  subtype_term:
    preferred_term: seizures, benign familial infantile, 3
    term:
      id: MONDO:0011904
      label: seizures, benign familial infantile, 3
  description: >-
    Clinically intermediate variant in which seizure onset spans the late
    neonatal period through early infancy. Caused by heterozygous SCN2A missense
    variants encoding the Nav1.2 voltage-gated sodium channel alpha subunit.
  evidence:
  - reference: PMID:12243921
    reference_title: Sodium-channel defects in benign familial neonatal-infantile seizures.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we describe a clinically intermediate variant, benign familial
      neonatal-infantile seizures, with mutations in the sodium-channel subunit
      gene SCN2A.
    explanation: The original report defines the SCN2A-associated neonatal-infantile familial subtype.
- name: SCN8A-related BFIS
  display_name: SCN8A-related Benign Familial Infantile Seizures
  subtype_term:
    preferred_term: seizures, benign familial infantile, 5
    term:
      id: MONDO:0014903
      label: seizures, benign familial infantile, 5
  description: >-
    Rare familial subtype caused by specific heterozygous SCN8A variants, with
    afebrile seizures beginning in the first or second year and generally normal
    development. Variant-specific evidence is essential because other SCN8A
    variants cause developmental and epileptic encephalopathy.
  evidence:
  - reference: PMID:26677014
    reference_title: Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In 3 families with a total of 16 affected members, we identified the same,
      cosegregating heterozygous missense mutation (c.4447G>A; p.E1483K) in
      SCN8A, encoding a voltage-gated sodium channel.
    explanation: Segregation of a recurrent SCN8A variant across three families supports this rare subtype.
inheritance:
- name: Autosomal dominant
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  description: >-
    BFIE is inherited in an autosomal dominant pattern with high but not
    complete penetrance. PRRT2, SCN2A, SCN8A, and ANKH variants segregate
    vertically across multiple generations in reported pedigrees.
  evidence:
  - reference: PMID:22243967
    reference_title: PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Benign familial infantile epilepsy (BFIE) is a self-limited seizure
      disorder that occurs in infancy and has autosomal-dominant inheritance.
    explanation: The PRRT2 discovery paper explicitly defines BFIE as an autosomal-dominant infantile seizure disorder.
  - reference: PMID:29334453
    reference_title: PRRT2-Related Disorder.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Reduced penetrance and variable expressivity are commonly observed,
      leading to considerable phenotypic variability among heterozygous family
      members. Each child of an individual with a heterozygous PRRT2 pathogenic
      variant has a 50% chance of inheriting the pathogenic variant.
    explanation: GeneReviews defines both reduced penetrance and the 50% recurrence risk for the major molecular subtype.
genetic:
- name: PRRT2
  association: Causal loss-of-function variant
  gene_term:
    preferred_term: PRRT2
    term:
      id: hgnc:30500
      label: PRRT2
  notes: >-
    Heterozygous truncating PRRT2 variants are the most common cause of BFIE
    (~80% of families) and ICCA (>90% of families). The recurrent
    c.649dupC/p.R217fsX224 frameshift is the predominant pathogenic allele and
    is predicted to cause haploinsufficiency.
  evidence:
  - reference: PMID:22243967
    reference_title: PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We have identified heterozygous mutations in PRRT2, which encodes
      proline-rich transmembrane protein 2, in 14 of 17 families (82%) affected
      by BFIE, indicating that PRRT2 mutations are the most frequent cause of
      this disorder.
    explanation: This is the discovery paper establishing PRRT2 as the major BFIE gene.
  - reference: PMID:23077018
    reference_title: PRRT2 phenotypic spectrum includes sporadic and fever-related infantile seizures.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      PRRT2 mutations are present in >80% of BFIE and >90% ICCA families, but
      are not a common cause of other forms of infantile epilepsy.
    explanation: Independent replication of PRRT2 mutation frequency in BFIE and ICCA cohorts.
  - reference: PMID:23343561
    reference_title: "Role of PRRT2 in common paroxysmal neurological disorders: a gene with remarkable pleiotropy."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The vast majority of these mutations are truncating and are predicted to
      lead to haploinsufficiency.
    explanation: Reviews the haploinsufficiency mechanism that unifies PRRT2-related BFIE, ICCA, and PKD.
- name: SCN2A
  association: Causal variant
  gene_term:
    preferred_term: SCN2A
    term:
      id: hgnc:10588
      label: SCN2A
  notes: >-
    Heterozygous SCN2A missense variants cause benign familial neonatal-infantile
    seizures (BFNIS), a clinically intermediate phenotype with onset spanning
    the late neonatal period into infancy.
  evidence:
  - reference: PMID:12243921
    reference_title: Sodium-channel defects in benign familial neonatal-infantile seizures.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we describe a clinically intermediate variant, benign familial
      neonatal-infantile seizures, with mutations in the sodium-channel subunit
      gene SCN2A.
    explanation: Original identification of SCN2A as the gene underlying benign familial neonatal-infantile seizures.
  - reference: PMID:29844171
    reference_title: Dynamic action potential clamp predicts functional separation in mild familial and severe de novo forms of SCN2A epilepsy.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Dynamic clamp was also able to functionally separate the L1563V variant,
      seen in benign familial neonatal-infantile seizures from R1882Q, seen in
      DEE, suggesting a diagnostic potential for this type of analysis.
    explanation: Functional modeling shows that a familial SCN2A allele differs from a severe de novo encephalopathy allele.
- name: SCN8A
  association: Causal variant (mild end of SCN8A spectrum)
  gene_term:
    preferred_term: SCN8A
    term:
      id: hgnc:10596
      label: SCN8A
  notes: >-
    SCN8A variants are an uncommon cause of self-limited familial epilepsy of
    neonatal/infantile onset; the same gene more often causes severe SCN8A
    developmental and epileptic encephalopathy.
  evidence:
  - reference: PMID:26677014
    reference_title: Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In 3 families with a total of 16 affected members, we identified the same,
      cosegregating heterozygous missense mutation (c.4447G>A; p.E1483K) in
      SCN8A, encoding a voltage-gated sodium channel.
    explanation: A recurrent cosegregating SCN8A allele directly supports familial causation.
- name: ANKH
  association: Causal recurrent start-region variant
  gene_term:
    preferred_term: ANKH
    term:
      id: hgnc:15492
      label: ANKH
  notes: >-
    The recurrent heterozygous c.-11C>T change upstream of the normal
    translation-initiation codon has now segregated with self-limited familial
    infantile epilepsy in two families. The epilepsy mechanism remains
    unresolved; a family history of chondrocalcinosis or recurrent acute joint
    pain can be a diagnostic clue.
  evidence:
  - reference: PMID:40574727
    reference_title: "Recurrent c.-11C>T change located upstream of the normal ATG initiation codon of ANKH causes self-limited familial infantile epilepsy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Short-read genome/exome sequencing and comparative bioinformatic analysis
      of the variants of five affected individuals and one unaffected individual
      revealed ANKH c.-11C>T as the causative pathogenic variant in this family,
      segregating with the disease.
    explanation: Segregation in a second reported family supports the recurrent ANKH start-region variant as a rare cause.
pathophysiology:
- name: PRRT2 Loss-of-Function and Impaired Synaptic Vesicle Release
  description: >-
    PRRT2 encodes a presynaptic, transmembrane-anchored protein that interacts
    with SNAP-25 and synaptotagmin 1/2 and contributes to the
    calcium-dependent neurotransmitter release machinery. Heterozygous
    truncating PRRT2 variants cause haploinsufficiency in presynaptic terminals,
    impairing synchronous neurotransmitter release and altering cortical and
    basal-ganglia network excitability. This presynaptic defect is the leading
    mechanistic model for the shared pathogenesis of BFIE, ICCA, and PKD.
  role: central_effector
  genes:
  - preferred_term: PRRT2
    term:
      id: hgnc:30500
      label: PRRT2
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  biological_processes:
  - preferred_term: neurotransmitter secretion
    modifier: DECREASED
    term:
      id: GO:0007269
      label: neurotransmitter secretion
  - preferred_term: synaptic vesicle exocytosis
    modifier: DECREASED
    term:
      id: GO:0016079
      label: synaptic vesicle exocytosis
  locations:
  - preferred_term: brain
    term:
      id: UBERON:0000955
      label: brain
  - preferred_term: cerebral cortex
    term:
      id: UBERON:0000956
      label: cerebral cortex
  - preferred_term: striatum
    term:
      id: UBERON:0002435
      label: striatum
  evidence:
  - reference: PMID:23343561
    reference_title: "Role of PRRT2 in common paroxysmal neurological disorders: a gene with remarkable pleiotropy."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      PRRT2 is a largely uncharacterised protein. It is expressed in the brain
      and has been demonstrated to interact with SNAP-25, a component of the
      molecular machinery involved in the release of neurotransmitters at the
      presynaptic membrane.
    explanation: Review summarizing prior in vitro biochemical work establishing PRRT2 presynaptic localization and SNAP-25 interaction.
  - reference: PMID:27052163
    reference_title: PRRT2 Is a Key Component of the Ca(2+)-Dependent Neurotransmitter Release Machinery.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      We show that PRRT2 is enriched in presynaptic terminals and that its
      silencing decreases the number of synapses and increases the number of
      docked synaptic vesicles at rest.
    explanation: Direct cellular evidence that PRRT2 loss perturbs synaptic vesicle pools.
  - reference: PMID:27052163
    reference_title: PRRT2 Is a Key Component of the Ca(2+)-Dependent Neurotransmitter Release Machinery.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      PRRT2-silenced neurons exhibit a severe impairment of synchronous release,
      attributable to a sharp decrease in release probability and Ca(2+)
      sensitivity and associated with a marked increase of the
      asynchronous/synchronous release ratio.
    explanation: Loss of PRRT2 specifically impairs calcium-dependent synchronous neurotransmitter release.
  - reference: PMID:27052163
    reference_title: PRRT2 Is a Key Component of the Ca(2+)-Dependent Neurotransmitter Release Machinery.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      PRRT2 interacts with the synaptic proteins SNAP-25 and synaptotagmin 1/2.
    explanation: Defines the molecular interactions placing PRRT2 in the SNARE/Ca2+-sensing release machinery.
  - reference: PMID:34133925
    reference_title: PRRT2 modulates presynaptic Ca(2+) influx by interacting with P/Q-type channels.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      At presynaptic terminals lacking PRRT2, P/Q-type Ca2+ channels reduce their
      clustering at the active zone, with a corresponding decrease in the
      P/Q-dependent presynaptic Ca2+ signal.
    explanation: Direct cellular evidence connects PRRT2 loss to impaired Cav2.1 active-zone targeting and calcium influx.
  downstream:
  - target: PRRT2-Deficient Network Hyperexcitability
    causal_link_type: DIRECT
    description: >-
      Altered excitatory and inhibitory synaptic transmission after PRRT2 loss
      destabilizes neuronal networks and produces heightened spontaneous and
      evoked activity.
    evidence:
    - reference: PMID:29912316
      reference_title: Constitutive Inactivation of the PRRT2 Gene Alters Short-Term Synaptic Plasticity and Promotes Network Hyperexcitability in Hippocampal Neurons.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        At the network level these complex synaptic effects resulted in a state
        of heightened spontaneous and evoked activity that was associated with
        increased excitability of excitatory neurons in both PRRT2 knockout
        primary cultures and acute hippocampal slices.
      explanation: PRRT2-null neuronal systems directly show the intervening network-hyperexcitability state.
- name: PRRT2-Deficient Network Hyperexcitability
  description: >-
    PRRT2 loss changes short-term synaptic plasticity in both excitatory and
    inhibitory neurons. The net effect in primary hippocampal cultures and acute
    slices is unstable, hyperexcitable network activity, providing an
    experimentally observed bridge between the presynaptic lesion and seizures.
  role: central_effector
  genes:
  - preferred_term: PRRT2
    term:
      id: hgnc:30500
      label: PRRT2
  cell_types:
  - preferred_term: glutamatergic neuron
    term:
      id: CL:0000679
      label: glutamatergic neuron
  - preferred_term: GABAergic neuron
    term:
      id: CL:0000617
      label: GABAergic neuron
  - preferred_term: hippocampal neuron
    term:
      id: CL:0002608
      label: hippocampal neuron
  biological_processes:
  - preferred_term: chemical synaptic transmission
    modifier: DYSREGULATED
    term:
      id: GO:0007268
      label: chemical synaptic transmission
  - preferred_term: regulation of membrane potential
    modifier: DYSREGULATED
    term:
      id: GO:0042391
      label: regulation of membrane potential
  locations:
  - preferred_term: hippocampal formation
    term:
      id: UBERON:0002421
      label: hippocampal formation
  evidence:
  - reference: PMID:29912316
    reference_title: Constitutive Inactivation of the PRRT2 Gene Alters Short-Term Synaptic Plasticity and Promotes Network Hyperexcitability in Hippocampal Neurons.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      The data indicate the existence of network instability/hyperexcitability
      as the possible basis of the paroxysmal phenotypes associated with PRRT2
      mutations.
    explanation: The experimental study identifies network hyperexcitability as the likely basis of PRRT2 paroxysmal phenotypes.
  downstream:
  - target: Focal-Onset Infantile Seizures
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - developmentally susceptible infant cortical networks
    description: Hyperexcitable neuronal networks predispose infants with PRRT2 loss to focal-onset seizures.
    evidence:
    - reference: PMID:22243967
      reference_title: PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Benign familial infantile epilepsy (BFIE) is a self-limited seizure
        disorder that occurs in infancy and has autosomal-dominant inheritance.
      explanation: Human genetic evidence links PRRT2 loss to the self-limited infantile seizure phenotype.
  - target: Seizure Clusters
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - developmentally susceptible infant cortical networks
    description: Network instability manifests clinically as recurrent clusters of brief infantile seizures.
    evidence:
    - reference: PMID:31901402
      reference_title: The clinical and genetic spectrum in infants with (an) unprovoked cluster(s) of focal seizures.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        In 12 individuals a pathogenic variation in PRRT2 gene or complete
        deletion was identified.
      explanation: A cluster-seizure cohort directly identifies PRRT2 pathogenic variants or deletion in affected infants.
  - target: Focal-to-Bilateral Tonic-Clonic Seizures
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - developmentally susceptible infant cortical networks
    description: Focal network seizures can spread bilaterally to tonic-clonic activity.
    evidence:
    - reference: PMID:31901402
      reference_title: The clinical and genetic spectrum in infants with (an) unprovoked cluster(s) of focal seizures.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        All patients had focal motor or non-motor seizures, in 12 (52%) followed
        by bilateral (tonic)clonic seizures.
      explanation: The infant cluster cohort directly documents focal seizures followed by bilateral tonic-clonic spread.
- name: Pleiotropic PRRT2 Effects Across Cortex and Basal Ganglia
  description: >-
    PRRT2 mutations exhibit anatomical and temporal pleiotropy: the same
    haploinsufficient allele produces cortical infantile seizures (BFIE) early
    in life and basal-ganglia paroxysmal kinesigenic dyskinesia (PKD) later in
    childhood or adolescence. ICCA represents the co-expression of both
    phenotypes within an individual or family.
  role: pleiotropy_mechanism
  genes:
  - preferred_term: PRRT2
    term:
      id: hgnc:30500
      label: PRRT2
  locations:
  - preferred_term: cerebral cortex
    term:
      id: UBERON:0000956
      label: cerebral cortex
  - preferred_term: striatum
    term:
      id: UBERON:0002435
      label: striatum
  evidence:
  - reference: PMID:22243967
    reference_title: PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      PRRT2 mutations elicit pleiotropy in terms of both age of expression
      (infancy versus later childhood) and anatomical substrate (cortex versus
      basal ganglia).
    explanation: Directly supports the pleiotropy mechanism distinguishing BFIE from PKD within the same gene.
  downstream:
  - target: Paroxysmal Kinesigenic Dyskinesia
    causal_link_type: DIRECT
    description: PRRT2 loss-of-function produces adolescent-onset paroxysmal kinesigenic dyskinesia in a subset of carriers, defining the ICCA syndrome when combined with infantile seizures.
    evidence:
    - reference: PMID:22243967
      reference_title: PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We also report PRRT2 mutations in five of six (83%) families affected by
        infantile convulsions and choreoathetosis (ICCA) syndrome, a familial
        syndrome in which infantile seizures and an adolescent-onset movement
        disorder, paroxysmal kinesigenic choreoathetosis (PKC), co-occur.
      explanation: Directly supports PRRT2-mediated PKD/PKC as the downstream movement-disorder phenotype in ICCA families.
- name: SCN2A Nav1.2 Variant-Specific Excitability
  description: >-
    Heterozygous SCN2A variants can produce mild familial neonatal-infantile
    seizures or severe developmental and epileptic encephalopathy. Functional
    effects and clinical consequences are variant-specific; dynamic
    action-potential clamp distinguishes the familial L1563V allele from severe
    de novo alleles without supporting a single direction of effect for every
    SCN2A-associated epilepsy.
  role: trigger
  genes:
  - preferred_term: SCN2A
    term:
      id: hgnc:10588
      label: SCN2A
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  biological_processes:
  - preferred_term: neuronal action potential
    modifier: DYSREGULATED
    term:
      id: GO:0019228
      label: neuronal action potential
  locations:
  - preferred_term: cerebral cortex
    term:
      id: UBERON:0000956
      label: cerebral cortex
  evidence:
  - reference: PMID:29844171
    reference_title: Dynamic action potential clamp predicts functional separation in mild familial and severe de novo forms of SCN2A epilepsy.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Overall, the study shows a strong correlation between clinical phenotype,
      SCN2A genotype, and functional modeling.
    explanation: Electrophysiologic modeling supports variant-specific Nav1.2 dysfunction rather than an unqualified gene-wide mechanism.
  downstream:
  - target: Focal-Onset Infantile Seizures
    causal_link_type: DIRECT
    description: Familial SCN2A variants can produce self-limited neonatal-infantile focal seizures.
    evidence:
    - reference: PMID:12243921
      reference_title: Sodium-channel defects in benign familial neonatal-infantile seizures.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Here, we describe a clinically intermediate variant, benign familial
        neonatal-infantile seizures, with mutations in the sodium-channel
        subunit gene SCN2A.
      explanation: The original family study directly links SCN2A variants to the mild familial seizure phenotype.
- name: SCN8A Nav1.6 Familial Epilepsy Association
  description: >-
    The recurrent SCN8A p.E1483K allele cosegregates with a mild familial
    infantile seizure and dyskinesia phenotype. SCN8A encodes a voltage-gated
    sodium channel, but the precise functional direction of this familial allele
    is not asserted here because the cited family study is clinical.
  role: trigger
  genes:
  - preferred_term: SCN8A
    term:
      id: hgnc:10596
      label: SCN8A
  biological_processes:
  - preferred_term: neuronal action potential
    modifier: DYSREGULATED
    term:
      id: GO:0019228
      label: neuronal action potential
  evidence:
  - reference: PMID:26677014
    reference_title: Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Fifteen affected members presented with afebrile focal or generalized
      tonic-clonic seizures during the first to second year of life; 5 of them
      experienced single unprovoked seizures later on.
    explanation: Three-family phenotyping establishes the mild infantile seizure phenotype of the recurrent SCN8A allele.
  downstream:
  - target: Focal-Onset Infantile Seizures
    causal_link_type: DIRECT
    description: The familial SCN8A allele is associated with afebrile focal seizures in infancy.
    evidence:
    - reference: PMID:26677014
      reference_title: Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Fifteen affected members presented with afebrile focal or generalized
        tonic-clonic seizures during the first to second year of life; 5 of them
        experienced single unprovoked seizures later on.
      explanation: The reported carriers directly connect the familial allele to infantile focal or tonic-clonic seizures.
- name: ANKH Start-Region Variant With Unresolved Epilepsy Mechanism
  description: >-
    The recurrent ANKH c.-11C>T start-region variant segregates with
    self-limited familial infantile epilepsy in two families, but its molecular
    effect in neurons and the pathway from ANKH dysfunction to seizures remain
    unresolved.
  role: trigger
  genes:
  - preferred_term: ANKH
    term:
      id: hgnc:15492
      label: ANKH
  evidence:
  - reference: PMID:40574727
    reference_title: "Recurrent c.-11C>T change located upstream of the normal ATG initiation codon of ANKH causes self-limited familial infantile epilepsy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      To our knowledge, we report the second family with autosomal dominant
      epilepsy caused by an ANKH c.-11C>T variant.
    explanation: Recurrence and segregation support causation while leaving the neuronal mechanism open.
  downstream:
  - target: Focal-Onset Infantile Seizures
    causal_link_type: UNKNOWN
    description: The ANKH variant is genetically associated with focal and bilateral tonic-clonic infantile seizures, but the intervening mechanism is unknown.
    evidence:
    - reference: PMID:40574727
      reference_title: "Recurrent c.-11C>T change located upstream of the normal ATG initiation codon of ANKH causes self-limited familial infantile epilepsy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        All affected family members experienced focal and/or bilateral
        tonic-clonic seizures, sometimes triggered by fever or infection, with
        seizure onset predominantly before the age of 2 years.
      explanation: The second ANKH family directly supplies the downstream seizure phenotype.
phenotypes:
- name: Focal-Onset Infantile Seizures
  category: Neurological
  diagnostic: true
  description: >-
    Affected infants present with brief focal-onset seizures, often clustered,
    sometimes with secondary bilateral spread to tonic-clonic activity. Onset is
    typically between 3 and 12 months of age, on a background of normal
    development, neurological examination, and interictal EEG.
  phenotype_term:
    preferred_term: Focal-onset seizure
    term:
      id: HP:0007359
      label: Focal-onset seizure
  evidence:
  - reference: PMID:22243967
    reference_title: PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Benign familial infantile epilepsy (BFIE) is a self-limited seizure
      disorder that occurs in infancy and has autosomal-dominant inheritance.
    explanation: The discovery paper defines BFIE clinically as a self-limited infantile seizure disorder.
  - reference: PMID:37170076
    reference_title: Peri-ictal EEG in infants with PRRT2-related self-limited infantile epilepsy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Ten infants presented with focal seizures at a median age of 5 months
      (range: 3-6 months).
    explanation: A genetically confirmed PRRT2 cohort supplies seizure type and typical onset timing.
- name: Focal-to-Bilateral Tonic-Clonic Seizures
  category: Neurological
  description: >-
    Focal motor or non-motor seizures frequently spread to bilateral
    tonic-clonic activity; some clinical reports use the less specific
    “bilateral tonic-clonic” description when focal onset is not captured.
  phenotype_term:
    preferred_term: Bilateral tonic-clonic seizure with focal onset
    term:
      id: HP:0007334
      label: Bilateral tonic-clonic seizure with focal onset
  evidence:
  - reference: PMID:31901402
    reference_title: The clinical and genetic spectrum in infants with (an) unprovoked cluster(s) of focal seizures.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All patients had focal motor or non-motor seizures, in 12 (52%) followed
      by bilateral (tonic)clonic seizures.
    explanation: The cohort directly documents focal-to-bilateral seizure evolution.
- name: Seizure Clusters
  category: Neurological
  description: >-
    Seizures typically occur in clusters, with multiple events over hours or
    days, followed by long seizure-free intervals. This temporal pattern is a
    characteristic feature of BFIE.
  phenotype_term:
    preferred_term: Recurrent seizure clusters
    term:
      id: HP:0001250
      label: Seizure
    temporality: RECURRENT
  evidence:
  - reference: PMID:23077018
    reference_title: PRRT2 phenotypic spectrum includes sporadic and fever-related infantile seizures.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Benign familial infantile epilepsy (BFIE) is an autosomal dominant
      epilepsy syndrome characterized by afebrile seizures beginning at about 6
      months of age.
    explanation: Defines BFIE clinically as an autosomal dominant afebrile infantile-seizure syndrome.
  - reference: PMID:31901402
    reference_title: The clinical and genetic spectrum in infants with (an) unprovoked cluster(s) of focal seizures.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The mean cluster duration was 2.9 days (range 1-13) (see Table 1). Twelve
      infants had only one cluster.
    explanation: The infant cohort quantifies cluster duration and shows that a single cluster can occur.
- name: Paroxysmal Kinesigenic Dyskinesia
  category: Neurological
  description: >-
    PRRT2-related BFIE families can also show adolescent-onset paroxysmal
    kinesigenic dyskinesia/choreoathetosis, defining the ICCA overlap syndrome
    when combined with infantile seizures.
  phenotype_term:
    preferred_term: Paroxysmal kinesigenic dyskinesia
    term:
      id: HP:0007166
      label: Paroxysmal dyskinesia
  evidence:
  - reference: PMID:22243967
    reference_title: PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We also report PRRT2 mutations in five of six (83%) families affected by infantile convulsions and choreoathetosis (ICCA) syndrome, a familial syndrome in which infantile seizures and an adolescent-onset movement disorder, paroxysmal kinesigenic choreoathetosis (PKC), co-occur.
    explanation: >-
      The PRRT2 discovery paper directly links PRRT2-related BFIE/ICCA families
      to adolescent-onset paroxysmal kinesigenic choreoathetosis, supporting
      the local paroxysmal dyskinesia phenotype and resolving the existing
      pathograph target.
progression:
- phase: Seizure clusters in infancy
  age_range: 3-12 months (typical)
  notes: >-
    Affected infants present with clusters of focal-onset seizures, often within
    a single day or over several days, on a background of normal development
    and neurological examination. Interictal EEG is characteristically normal.
  evidence:
  - reference: PMID:23077018
    reference_title: PRRT2 phenotypic spectrum includes sporadic and fever-related infantile seizures.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Benign familial infantile epilepsy (BFIE) is an autosomal dominant
      epilepsy syndrome characterized by afebrile seizures beginning at about 6
      months of age.
    explanation: Supports the infantile-onset seizure phase centered on ~6 months.
- phase: Spontaneous remission
  age_range: infancy to early childhood
  notes: >-
    Seizure freedom is usually reached during infancy or by the end of the
    second year. Persistence beyond age 2 years, frequent recurrence, or
    treatment resistance should prompt reassessment for another genetic
    epilepsy; the reported ANKH families can remit somewhat later.
  evidence:
  - reference: PMID:31901402
    reference_title: The clinical and genetic spectrum in infants with (an) unprovoked cluster(s) of focal seizures.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      When clusters reoccur frequently, when seizures are more therapy-resistant
      and when seizures persist beyond the age of 2 years, another diagnosis or
      causative gene is likely.
    explanation: The cohort bounds the expected self-limited window and identifies red flags for diagnostic reassessment.
  - reference: PMID:40574727
    reference_title: "Recurrent c.-11C>T change located upstream of the normal ATG initiation codon of ANKH causes self-limited familial infantile epilepsy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Patients responded well to antiseizure medication, and seizures resolved
      completely before the age of 4 years.
    explanation: The rare ANKH subtype demonstrates a still self-limited but somewhat broader remission window.
- phase: Later seizure recurrence or episodic PRRT2 manifestations
  age_range: childhood to adulthood
  notes: >-
    A minority have later isolated seizures. PRRT2 carriers can develop
    paroxysmal kinesigenic dyskinesia or migraine after the infantile epilepsy
    has remitted; these later manifestations reflect pleiotropy rather than
    persistence of the infantile syndrome.
  evidence:
  - reference: PMID:38160512
    reference_title: Neurodevelopmental outcomes in a cohort of Australian families with self-limited familial epilepsy of neonatal/infantile onset.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Ten of 50 individuals (20%) had seizure recurrence, aged 8-65 years.
      Median time from last neonatal/infantile seizure was 11.8/12.8 years.
    explanation: The mixed familial neonatal/infantile cohort quantifies a non-zero risk of later seizure recurrence.
  - reference: PMID:38160512
    reference_title: Neurodevelopmental outcomes in a cohort of Australian families with self-limited familial epilepsy of neonatal/infantile onset.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Paroxysmal kinesiogenic dyskinesia (n=5) occurred in 4 families and
      hemiplegic migraine (n=8) in 3 families.
    explanation: The long-term cohort documents later episodic movement and migraine phenotypes.
- phase: Long-term outcome
  notes: >-
    Most individuals achieve normal cognitive and adaptive functioning, though
    a minority show mild neurodevelopmental concerns, particularly when seizure
    burden in infancy was high or treatment duration was prolonged.
  evidence:
  - reference: PMID:38160512
    reference_title: Neurodevelopmental outcomes in a cohort of Australian families with self-limited familial epilepsy of neonatal/infantile onset.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Vineland-3 identified 3 had low-average and 3 had mild-moderately impaired
      functioning. The majority (82%) were average.
    explanation: Adaptive function outcomes support generally favorable long-term outcome with a minority showing mild impairment.
  - reference: PMID:24958006
    reference_title: Evaluation of clinical course and neurocognition in children with self-limited infantile epilepsy in a Turkish cohort study.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Fine motor and gross motor skills, language, adaptive personal/social
      skills were near-normal in all patients with self-limited familial
      infantile epilepsy.
    explanation: A separate cohort supports generally favorable development in the familial subgroup.
diagnosis:
- name: Electroclinical recognition with interictal and peri-ictal EEG
  diagnosis_term:
    preferred_term: electroencephalography
    term:
      id: NCIT:C38054
      label: Electroencephalography
  presence: SUPPORTIVE
  description: >-
    Diagnosis begins with the characteristic age, brief afebrile focal seizures
    in clusters, normal development, and compatible family history. The
    interictal EEG is usually normal; an EEG obtained within 24 hours of a
    seizure can show bilateral temporo-occipital focal epileptiform discharges.
    A normal interictal study therefore does not exclude the syndrome.
  evidence:
  - reference: PMID:37170076
    reference_title: Peri-ictal EEG in infants with PRRT2-related self-limited infantile epilepsy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Pathogenic PRRT2 variants cause self-limited (familial) infantile epilepsy
      (SeLIE), which is responsive to sodium channel blocking antiseizure
      medications. The interictal EEG is typically normal.
    explanation: The EEG cohort explicitly establishes the usual interictal pattern.
  - reference: PMID:37170076
    reference_title: Peri-ictal EEG in infants with PRRT2-related self-limited infantile epilepsy.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Seven of the eight infants with an EEG performed within 24 h of the most
      recent seizure had epileptiform discharges.
    explanation: Timing-dependent peri-ictal abnormalities explain why an otherwise normal interictal EEG can coexist with the syndrome.
- name: Molecular genetic testing for etiologic assignment
  diagnosis_term:
    preferred_term: genetic testing
    term:
      id: NCIT:C15709
      label: Genetic Testing
  presence: RECOMMENDED_FOR_ETIOLOGIC_ASSIGNMENT
  description: >-
    Sequence and copy-number analysis should prioritize PRRT2 and include SCN2A
    and SCN8A; ANKH c.-11C>T is a rare consideration, especially when joint pain
    or chondrocalcinosis segregates in the family. Broad testing is appropriate
    for atypical, refractory, developmentally concerning, or PRRT2-negative
    presentations.
  evidence:
  - reference: PMID:29334453
    reference_title: PRRT2-Related Disorder.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The diagnosis of PRRT2-related disorder is established in a proband with
      suggestive findings and a heterozygous PRRT2 pathogenic variant identified
      by molecular genetic testing.
    explanation: GeneReviews directly supports molecular confirmation for PRRT2-related disease.
  - reference: PMID:40574727
    reference_title: "Recurrent c.-11C>T change located upstream of the normal ATG initiation codon of ANKH causes self-limited familial infantile epilepsy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      ANKH-associated epilepsy should be considered in SeLFIE, especially in
      cases with a family history of chondrocalcinosis or recurrent acute joint
      pain episodes.
    explanation: The recurrent-family report supplies a specific clue for extending testing to ANKH.
differential_diagnoses:
- name: Self-limited familial neonatal epilepsy
  disease_term:
    preferred_term: benign neonatal seizures
    term:
      id: MONDO:0016027
      label: benign neonatal seizures
  description: >-
    Both disorders are autosomal dominant and self-limited. Predominantly
    neonatal onset and a KCNQ2/KCNQ3 molecular diagnosis favor familial neonatal
    epilepsy; onset later in infancy, clustering, and PRRT2 favor the focal
    disease curated here. SCN2A-associated neonatal-infantile epilepsy bridges
    the age boundary and is retained as an overlapping subtype.
  distinguishing_features:
  - Seizure onset predominantly in the neonatal period
  - KCNQ2 or KCNQ3 pathogenic variant
  evidence:
  - reference: PMID:12243921
    reference_title: Sodium-channel defects in benign familial neonatal-infantile seizures.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Two autosomal dominant disorders present in the first year of life: benign
      familial neonatal seizures, which is associated with potassium-channel
      gene defects; and benign familial infantile seizures, for which no genes
      have been identified.
    explanation: The original SCN2A study explicitly separates neonatal and infantile familial syndromes while defining the intermediate form.
- name: PCDH19-related developmental and epileptic encephalopathy
  disease_term:
    preferred_term: developmental and epileptic encephalopathy, 9
    term:
      id: MONDO:0010246
      label: developmental and epileptic encephalopathy, 9
  description: >-
    PCDH19-related epilepsy can initially resemble infantile clustered focal
    seizures. Recurrent, treatment-resistant clusters, persistence after age 2
    years, developmental concerns, or identification of a pathogenic PCDH19
    variant argue against classic self-limited familial infantile epilepsy.
  distinguishing_features:
  - Recurrent or treatment-resistant clusters
  - Seizures persisting beyond age 2 years
  - Developmental or behavioral concerns
  evidence:
  - reference: PMID:31901402
    reference_title: The clinical and genetic spectrum in infants with (an) unprovoked cluster(s) of focal seizures.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All had an initial diagnosis of S(F)IE which was adjusted in 5 individuals.
      In 12 individuals a pathogenic variation in PRRT2 gene or complete deletion
      was identified. Pathogenic variants in PCDH19 and KCNQ2 were found in
      respectively 3 and 1 individuals.
    explanation: Reclassification after genetic testing shows that PCDH19-related disease is a concrete phenocopy.
treatments:
- name: Sodium-Channel-Blocking Antiseizure Medication
  description: >-
    Carbamazepine or oxcarbazepine is often highly effective for acute seizure
    clusters in PRRT2-associated self-limited infantile epilepsy. Evidence is
    retrospective and observational rather than randomized, and treatment
    duration should be individualized in view of spontaneous remission.
  treatment_term:
    preferred_term: anticonvulsant agent therapy
    term:
      id: NCIT:C64172
      label: Anticonvulsant Therapy
    therapeutic_agent:
    - preferred_term: carbamazepine
      term:
        id: CHEBI:3387
        label: carbamazepine
    - preferred_term: oxcarbazepine
      term:
        id: CHEBI:7824
        label: oxcarbazepine
  target_phenotypes:
  - preferred_term: Focal-onset seizure
    term:
      id: HP:0007359
      label: Focal-onset seizure
  - preferred_term: Bilateral tonic-clonic seizure with focal onset
    term:
      id: HP:0007334
      label: Bilateral tonic-clonic seizure with focal onset
  evidence:
  - reference: PMID:36187725
    reference_title: "Efficacy, Tolerability, and Retention of Antiseizure Medications in PRRT2-Associated Infantile Epilepsy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Sodium channel blockers were used in 22 individuals and resulted in
      seizure freedom in all but 1 child, who showed a reduction of more than
      50% in seizure frequency.
    explanation: The largest treatment-response cohort directly supports high response to sodium-channel blockers.
  - reference: PMID:36187725
    reference_title: "Efficacy, Tolerability, and Retention of Antiseizure Medications in PRRT2-Associated Infantile Epilepsy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This study provides Class IV evidence that in individuals with
      PRRT2-associated infantile epilepsy, sodium channel blockers are associated
      with reduced seizure frequency but levetiracetam is not.
    explanation: The authors' evidence classification makes the observational limitation explicit.
  - reference: PMID:40401013
    reference_title: "PRRT 2-Related Epilepsy: From Self-Limited Infantile Epilepsy to Atypical Epilepsy Phenotypes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Thirty-seven children (n = 37/40, 93%) were treated with antiseizure
      medications, and sodium channel blockers were effective in most (20/27
      responded, 74%).
    explanation: A recent international cohort independently supports frequent response while showing that it is not universal.
- name: Supportive Management and Surveillance
  description: >-
    GeneReviews advises prompt fever treatment during the self-limited familial
    infantile epilepsy phase and regularly scheduled follow-up to monitor
    existing manifestations, response to supportive care, and emergence of new
    manifestations. This is supportive-care guidance, not evidence for a
    specific antiseizure medication.
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:29334453
    reference_title: PRRT2-Related Disorder.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Surveillance: Monitoring existing manifestations, the individual's
      response to supportive care, and the emergence of new manifestations
      requires regularly scheduled follow up with the treating neurologist as
      well as educators and social services. Agents/circumstances to avoid: For
      self-limited (familial) infantile epilepsy, treat fevers promptly.
    explanation: >-
      GeneReviews supplies separate supportive-care and surveillance guidance
      without asserting efficacy for a particular antiseizure medication.
clinical_trials:
- name: NCT06585605
  phase: NOT_APPLICABLE
  status: RECRUITING
  description: >-
    Multinational retrospective observational survey of epilepsy-dyskinesia
    syndromes, including genetic causes such as PRRT2, SCN2A, and SCN8A. It is
    relevant to ICCA and related familial overlap phenotypes but requires a
    pediatric movement disorder and is not a BFIE treatment trial.
  target_phenotypes:
  - preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  - preferred_term: Paroxysmal dyskinesia
    term:
      id: HP:0007166
      label: Paroxysmal dyskinesia
  evidence:
  - reference: clinicaltrials:NCT06585605
    reference_title: A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The Epilepsy-Dyskinesia Study aims to advance the understanding of the
      clinical and molecular spectrum of epilepsy-dyskinesia syndromes,
      monogenic diseases that cause both movement disorders and epilepsy.
    explanation: The registry summary establishes its combined epilepsy and dyskinesia scope.
  notes: Recruiting status checked on 2026-07-23; this is a broad observational study, not disease-specific efficacy evidence.
- name: NCT06967727
  phase: NOT_APPLICABLE
  status: RECRUITING
  description: >-
    Prospective registry and natural-history study collecting longitudinal
    clinical data and biospecimens from genetically diagnosed
    epilepsy-dyskinesia syndromes, including PRRT2-, SCN2A-, and SCN8A-related
    disease. It is broader than self-limited familial infantile epilepsy.
  target_phenotypes:
  - preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  - preferred_term: Paroxysmal dyskinesia
    term:
      id: HP:0007166
      label: Paroxysmal dyskinesia
  evidence:
  - reference: clinicaltrials:NCT06967727
    reference_title: Registry and Natural History of Epilepsy-Dyskinesia Syndromes
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The Registry and Natural History of Epilepsy-Dyskinesia Syndromes is
      focused on gathering longitudinal clinical data as well as biological
      samples (blood, urine, and/or skin/tissue) from male and female patients,
      of all ages, who have a genetic diagnosis of epilepsy-dyskinesia
      syndromes.
    explanation: The registry summary directly defines the longitudinal and biospecimen collection.
  notes: Recruiting status checked on 2026-07-23; this is a broad observational registry, not a therapeutic study.
animal_models:
- species: Mus musculus
  genotype: Constitutive Prrt2 knockout
  background: C57BL
  genes:
  - preferred_term: Prrt2
    term:
      id: MGI:1916267
      label: Prrt2
  category: Neurological
  description: >-
    Constitutive Prrt2-null mice model PRRT2 deficiency. They show paroxysmal
    movements, abnormal audiogenic motor behavior, increased sensitivity to
    pentylenetetrazole-induced convulsions, and cerebellar synaptic changes.
    Adult provoked-convulsion susceptibility is supportive but does not exactly
    reproduce the spontaneous infantile human seizure window.
  associated_phenotypes:
  - Paroxysmal movements
  - Increased chemically induced seizure susceptibility
  - Abnormal audiogenic motor behavior
  evidence:
  - reference: PMID:28007585
    reference_title: The PRRT2 knockout mouse recapitulates the neurological diseases associated with PRRT2 mutations.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      In addition, adult PRRT2 KO mice present abnormal motor behaviors
      characterized by wild running and jumping in response to audiogenic
      stimuli that are ineffective in wild type mice and an increased
      sensitivity to the convulsive effects of pentylentetrazol.
    explanation: The knockout model directly demonstrates paroxysmal behavior and increased provoked-convulsion sensitivity.
- species: Mus musculus
  genotype: Heterozygous and homozygous Prrt2 knockout allelic series
  genes:
  - preferred_term: Prrt2
    term:
      id: MGI:1916267
      label: Prrt2
  category: Neurological
  description: >-
    Heterozygous and homozygous Prrt2 knockout mice provide an allelic series
    for developmental timing. Synaptic-protein changes are strongest early
    postnatally and attenuate with age, while motor phenotypes occupy a later
    window. The study models age dependence but does not prove the mechanism of
    human infantile seizure remission.
  associated_phenotypes:
  - Age-dependent reduction of synaptic proteins
  - Transient motor incoordination
  evidence:
  - reference: PMID:34101060
    reference_title: Age-dependent neurological phenotypes in a mouse model of PRRT2-related diseases.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      We show that Prrt2 deletion reduces the levels of synaptic proteins in a
      dose-dependent manner that is most pronounced at postnatal day 5 (P5),
      attenuates at P60, and disappears by P180.
    explanation: The allelic-series model directly demonstrates an age-dependent molecular phenotype.
experimental_models:
- name: PRRT2-null primary mouse hippocampal neuron model
  experimental_model_type: PRIMARY_CELL_CULTURE
  organism:
    preferred_term: mouse
    term:
      id: NCBITaxon:10090
      label: Mus musculus
  tissue_term:
    preferred_term: hippocampal formation
    term:
      id: UBERON:0002421
      label: hippocampal formation
  cell_types:
  - preferred_term: hippocampal neuron
    term:
      id: CL:0002608
      label: hippocampal neuron
  cell_source: Primary hippocampal neurons isolated from embryos carrying a constitutively inactivated Prrt2 gene
  culture_system: Primary neuronal cultures, autaptic cultures, and acute hippocampal slices
  conditions:
  - Prrt2 knockout
  - Wild-type comparison
  description: >-
    Primary Prrt2-null hippocampal neurons and related acute slices reproduce
    altered excitatory and inhibitory synaptic dynamics, network
    hyperexcitability, and defective P/Q-type calcium-channel targeting.
  publication: PMID:29912316
  modeled_mechanisms:
  - target: PRRT2-Deficient Network Hyperexcitability
    description: The model measures the net network consequence of altered excitatory and inhibitory transmission after PRRT2 loss.
    evidence:
    - reference: PMID:29912316
      reference_title: Constitutive Inactivation of the PRRT2 Gene Alters Short-Term Synaptic Plasticity and Promotes Network Hyperexcitability in Hippocampal Neurons.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        At the network level these complex synaptic effects resulted in a state
        of heightened spontaneous and evoked activity that was associated with
        increased excitability of excitatory neurons in both PRRT2 knockout
        primary cultures and acute hippocampal slices.
      explanation: Primary cultures and acute slices directly reproduce the curated hyperexcitability mechanism.
  - target: PRRT2 Loss-of-Function and Impaired Synaptic Vesicle Release
    description: Autaptic PRRT2-null neurons model impaired Cav2.1 targeting and calcium-dependent glutamatergic release.
    evidence:
    - reference: PMID:34133925
      reference_title: PRRT2 modulates presynaptic Ca(2+) influx by interacting with P/Q-type channels.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        The data highlight the central role of PRRT2 in ensuring the
        physiological Ca2+ sensitivity of the release machinery at glutamatergic
        synapses.
      explanation: The culture study directly supports the presynaptic calcium-sensitivity mechanism.
  findings: []
  evidence:
  - reference: PMID:29912316
    reference_title: Constitutive Inactivation of the PRRT2 Gene Alters Short-Term Synaptic Plasticity and Promotes Network Hyperexcitability in Hippocampal Neurons.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      In this work, we investigated the phenotype of primary hippocampal neurons
      obtained from mouse embryos in which the PRRT2 gene was constitutively
      inactivated.
    explanation: The publication explicitly defines the primary-neuron model and genetic perturbation.
datasets:
- accession: PMID:38160512
  title: Neurodevelopmental outcomes in a cohort of Australian families with self-limited familial epilepsy of neonatal/infantile onset.
  description: >-
    Australian multigenerational cohort of 15 families and 73 affected
    individuals with self-limited familial neonatal/infantile epilepsy; 50
    participants underwent in-depth phenotyping and adaptive-function
    assessment. The cohort spans PRRT2, KCNQ2, SCN2A, and SCN8A and is therefore
    broader than the focal infantile entity.
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  sample_count: 73
  conditions:
  - self-limited familial epilepsy of neonatal/infantile onset
  genes:
  - preferred_term: PRRT2
    term:
      id: hgnc:30500
      label: PRRT2
  - preferred_term: KCNQ2
    term:
      id: hgnc:6296
      label: KCNQ2
  - preferred_term: SCN2A
    term:
      id: hgnc:10588
      label: SCN2A
  - preferred_term: SCN8A
    term:
      id: hgnc:10596
      label: SCN8A
  publication: PMID:38160512
  findings: []
  evidence:
  - reference: PMID:38160512
    reference_title: Neurodevelopmental outcomes in a cohort of Australian families with self-limited familial epilepsy of neonatal/infantile onset.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Fifteen families participated. Fourteen had a genetic diagnosis (93%): 11
      pathogenic; PRRT2 (n=4), KCNQ2 (n=3), SCN2A (n=4), 3 likely pathogenic;
      KCNQ2 (n=1), SCN8A (n=2). Seizures affected 73 individuals (ages 1-76
      years); 30 children and 20 adults had in-depth phenotyping.
    explanation: The publication defines the cohort size, molecular composition, and deeply phenotyped subset.
review_notes: >-
  The MONDO record retains the historical name “benign familial infantile
  epilepsy”; current clinical usage favors “self-limited familial infantile
  epilepsy,” which is included as the primary synonym and used throughout the
  narrative. Scope is restricted to the infantile syndrome. Predominantly
  neonatal KCNQ2/KCNQ3 epilepsies are represented as a differential rather than
  expanded into the focal disease, while SCN2A neonatal-infantile disease is
  retained because it is the established intermediate subtype. PRRT2 is the
  major cause; SCN2A, SCN8A, and the recurrent ANKH c.-11C>T allele are rare
  causes, and variant-specific interpretation is required. Treatment evidence
  for sodium-channel blockers is observational. GeneReviews supportive-care
  guidance is represented separately and is not used as drug-efficacy evidence.
  No disease-specific interventional trial was identified; NCT06585605 and
  NCT06967727 are broad observational epilepsy-dyskinesia studies whose
  recruiting status was checked on 2026-07-23.
references:
- reference: PMID:12243921
  title: Sodium-channel defects in benign familial neonatal-infantile seizures.
  findings: []
- reference: PMID:22243967
  title: PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome.
  findings: []
- reference: PMID:23077018
  title: PRRT2 phenotypic spectrum includes sporadic and fever-related infantile seizures.
  findings: []
- reference: PMID:23343561
  title: "Role of PRRT2 in common paroxysmal neurological disorders: a gene with remarkable pleiotropy."
  findings: []
- reference: PMID:24958006
  title: Evaluation of clinical course and neurocognition in children with self-limited infantile epilepsy in a Turkish cohort study.
  findings: []
- reference: PMID:26677014
  title: Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation.
  findings: []
- reference: PMID:27052163
  title: PRRT2 Is a Key Component of the Ca(2+)-Dependent Neurotransmitter Release Machinery.
  findings: []
- reference: PMID:28007585
  title: The PRRT2 knockout mouse recapitulates the neurological diseases associated with PRRT2 mutations.
  findings: []
- reference: PMID:29334453
  title: PRRT2-Related Disorder.
  tags:
  - GeneReviews
  findings: []
- reference: PMID:29844171
  title: Dynamic action potential clamp predicts functional separation in mild familial and severe de novo forms of SCN2A epilepsy.
  findings: []
- reference: PMID:29912316
  title: Constitutive Inactivation of the PRRT2 Gene Alters Short-Term Synaptic Plasticity and Promotes Network Hyperexcitability in Hippocampal Neurons.
  findings: []
- reference: PMID:31901402
  title: The clinical and genetic spectrum in infants with (an) unprovoked cluster(s) of focal seizures.
  findings: []
- reference: PMID:34101060
  title: Age-dependent neurological phenotypes in a mouse model of PRRT2-related diseases.
  findings: []
- reference: PMID:34133925
  title: PRRT2 modulates presynaptic Ca(2+) influx by interacting with P/Q-type channels.
  findings: []
- reference: PMID:36187725
  title: "Efficacy, Tolerability, and Retention of Antiseizure Medications in PRRT2-Associated Infantile Epilepsy."
  findings: []
- reference: PMID:36775847
  title: "PRRT2-positive self-limited infantile epilepsy: Initial seizure characteristics and response to sodium channel blockers."
  findings: []
- reference: PMID:37170076
  title: Peri-ictal EEG in infants with PRRT2-related self-limited infantile epilepsy.
  findings: []
- reference: PMID:38160512
  title: Neurodevelopmental outcomes in a cohort of Australian families with self-limited familial epilepsy of neonatal/infantile onset.
  findings: []
- reference: PMID:40401013
  title: "PRRT 2-Related Epilepsy: From Self-Limited Infantile Epilepsy to Atypical Epilepsy Phenotypes."
  findings: []
- reference: PMID:40574727
  title: "Recurrent c.-11C>T change located upstream of the normal ATG initiation codon of ANKH causes self-limited familial infantile epilepsy."
  findings: []
- reference: clinicaltrials:NCT06585605
  title: A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
  findings: []
- reference: clinicaltrials:NCT06967727
  title: Registry and Natural History of Epilepsy-Dyskinesia Syndromes
  findings: []
discussions:
- discussion_id: gap_prrt2_pleiotropy_phenotype_determinant
  prompt: >-
    What determines whether a single PRRT2 loss-of-function allele (classically
    c.649dupC) manifests as infantile epilepsy (BFIE), later paroxysmal
    kinesigenic dyskinesia (PKD), the combined ICCA phenotype, or hemiplegic
    migraine, sometimes varying even among carriers within one family?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Pleiotropic PRRT2 Effects Across Cortex and Basal Ganglia
  - pathophysiology#PRRT2 Loss-of-Function and Impaired Synaptic Vesicle Release
  rationale: >-
    The same recurrent truncating PRRT2 allele predicted to cause
    haploinsufficiency produces phenotypes that differ in age of expression
    (infancy versus later childhood) and anatomical substrate (cortex versus
    basal ganglia). Because the primary lesion is shared, the factors selecting
    among BFIE, PKD, ICCA, and migraine (genetic modifiers, developmental timing
    of PRRT2-dependent release in different circuits, environmental triggers)
    remain a genuine mechanistic gap that curation cannot resolve from the
    single-gene defect alone.
  evidence:
  - reference: PMID:22243967
    reference_title: PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      PRRT2 mutations elicit pleiotropy in terms of both age of expression
      (infancy versus later childhood) and anatomical substrate (cortex versus
      basal ganglia).
    explanation: >-
      Documents the age-dependent and region-dependent pleiotropy whose
      determinants are the open question.
  - reference: PMID:23343561
    reference_title: "Role of PRRT2 in common paroxysmal neurological disorders: a gene with remarkable pleiotropy."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The vast majority of these mutations are truncating and are predicted to
      lead to haploinsufficiency.
    explanation: >-
      Establishes that a shared haploinsufficiency mechanism underlies the
      divergent phenotypes, so phenotype selection must be governed by factors
      beyond the primary allele.
  proposed_experiments:
  - experiment_id: exp_prrt2_knockin_allelic_circuit_timing
    name: PRRT2 knock-in allelic-series circuit-timing experiment
    description: >-
      Introduce the recurrent c.649dupC and other truncating PRRT2 alleles on
      defined genetic backgrounds and profile, across postnatal development,
      calcium-dependent synchronous release and network excitability separately
      in cortical and striatal circuits to test whether region-specific and
      age-specific release deficits predict the cortical-seizure versus
      basal-ganglia-dyskinesia phenotype.
    experiment_type:
      preferred_term: developmental circuit electrophysiology experiment
    perturbations:
    - name: PRRT2 truncating allele knock-in
      target: pathophysiology#PRRT2 Loss-of-Function and Impaired Synaptic Vesicle Release
      genes:
      - preferred_term: PRRT2
        term:
          id: hgnc:30500
          label: PRRT2
      description: >-
        Knock-in of c.649dupC and additional truncating alleles compared against
        matched wild-type controls.
    readouts:
    - name: Region-specific synchronous release and excitability
      target: pathophysiology#Pleiotropic PRRT2 Effects Across Cortex and Basal Ganglia
      biological_processes:
      - preferred_term: neurotransmitter secretion
        term:
          id: GO:0007269
          label: neurotransmitter secretion
        modifier: DECREASED
      - preferred_term: synaptic vesicle exocytosis
        term:
          id: GO:0016079
          label: synaptic vesicle exocytosis
        modifier: DECREASED
      assays:
      - preferred_term: multielectrode array recording
      - preferred_term: patch-clamp electrophysiology
      direction: NEGATIVE
    controls:
    - name: Wild-type littermates
      description: Matched wild-type animals profiled at the same developmental ages.
    decision_criterion: >-
      A circuit-timing model of pleiotropy is supported if release and
      excitability deficits are cortex-predominant during infancy and shift
      toward the basal ganglia at ages matching PKD onset.
    would_support:
    - pathophysiology#Pleiotropic PRRT2 Effects Across Cortex and Basal Ganglia
- discussion_id: gap_bfie_spontaneous_remission_developmental_window
  prompt: >-
    Why do PRRT2-related infantile seizures remit spontaneously by the second
    year while the same haploinsufficient allele can produce persistent
    paroxysmal kinesigenic dyskinesia later in the same individuals?
  kind: OPEN_QUESTION
  status: OPEN
  attaches_to:
  - pathophysiology#PRRT2 Loss-of-Function and Impaired Synaptic Vesicle Release
  rationale: >-
    The self-limiting course of the seizure phenotype is a defining and
    clinically reassuring feature of BFIE, yet its mechanistic basis is
    unexplained. Because PRRT2 haploinsufficiency persists lifelong, remission
    implies a developmental-window process (maturation of inhibitory circuits,
    compensatory presynaptic release proteins, or age-dependent PRRT2
    requirement) that resolves cortical hyperexcitability without correcting the
    genetic lesion, in contrast to the later-emerging and persistent movement
    disorder in the same carriers.
  evidence:
  - reference: PMID:22243967
    reference_title: PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Benign familial infantile epilepsy (BFIE) is a self-limited seizure
      disorder that occurs in infancy and has autosomal-dominant inheritance.
    explanation: >-
      Establishes the self-limited seizure course whose developmental basis is
      the open question.
  - reference: PMID:38160512
    reference_title: Neurodevelopmental outcomes in a cohort of Australian families with self-limited familial epilepsy of neonatal/infantile onset.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Paroxysmal kinesiogenic dyskinesia (n=5) occurred in 4 families and
      hemiplegic migraine (n=8) in 3 families.
    explanation: >-
      Documents the later-onset persistent PKD phenotype in the same families,
      contrasting with the transient seizure phase and framing the
      window-specific remission question.
  proposed_experiments:
  - experiment_id: exp_bfie_developmental_excitability_timecourse
    name: BFIE developmental excitability time-course experiment
    description: >-
      In a PRRT2-haploinsufficient model, quantify cortical network
      excitability, inhibitory-circuit maturation, and expression of candidate
      compensatory presynaptic release proteins across the infantile
      seizure-prone window and after the expected remission age to test whether
      remission tracks with maturation-driven normalization of synchronous
      release rather than with any change in PRRT2 dosage.
    experiment_type:
      preferred_term: longitudinal developmental profiling experiment
    perturbations:
    - name: PRRT2 haploinsufficiency
      target: pathophysiology#PRRT2 Loss-of-Function and Impaired Synaptic Vesicle Release
      genes:
      - preferred_term: PRRT2
        term:
          id: hgnc:30500
          label: PRRT2
      description: >-
        PRRT2 loss-of-function background profiled longitudinally against
        wild-type controls.
    readouts:
    - name: Excitability normalization over development
      target: pathophysiology#PRRT2 Loss-of-Function and Impaired Synaptic Vesicle Release
      biological_processes:
      - preferred_term: synaptic vesicle exocytosis
        term:
          id: GO:0016079
          label: synaptic vesicle exocytosis
        modifier: DECREASED
      - preferred_term: trans-synaptic signaling
        term:
          id: GO:0099537
          label: trans-synaptic signaling
        modifier: DYSREGULATED
      assays:
      - preferred_term: multielectrode array recording
      direction: NEGATIVE
    controls:
    - name: Wild-type developmental controls
      description: Matched wild-type samples profiled at the same ages.
    decision_criterion: >-
      A developmental-window model of remission is supported if network
      hyperexcitability and synchronous-release deficits normalize by the
      post-remission age despite unchanged PRRT2 dosage.
    would_support:
    - pathophysiology#PRRT2 Loss-of-Function and Impaired Synaptic Vesicle Release
- discussion_id: gap_bfie_synaptic_vs_channel_convergence
  prompt: >-
    Do the presynaptic-release route (PRRT2), the voltage-gated sodium-channel
    routes (SCN2A and SCN8A), and the unresolved ANKH route to self-limited
    familial infantile epilepsy converge on a single infantile
    hyperexcitability mechanism, or represent distinct pathways with a common
    clinical endpoint?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#PRRT2 Loss-of-Function and Impaired Synaptic Vesicle Release
  - pathophysiology#SCN2A Nav1.2 Variant-Specific Excitability
  - pathophysiology#SCN8A Nav1.6 Familial Epilepsy Association
  - pathophysiology#ANKH Start-Region Variant With Unresolved Epilepsy Mechanism
  rationale: >-
    BFIE is genetically heterogeneous, arising from a presynaptic
    release-machinery protein (PRRT2) and from ion-channel subunits (SCN2A,
    SCN8A), with a rare ANKH association whose neuronal mechanism remains
    unknown. Whether these lesions converge on a common infantile cortical
    hyperexcitability node, or produce the same self-limited phenotype by
    parallel routes, is unresolved and bears on whether the syndrome should be
    modeled as one mechanism with substitutable drivers or several convergent
    mechanisms.
  evidence:
  - reference: PMID:12243921
    reference_title: Sodium-channel defects in benign familial neonatal-infantile seizures.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we describe a clinically intermediate variant, benign familial
      neonatal-infantile seizures, with mutations in the sodium-channel subunit
      gene SCN2A.
    explanation: >-
      Documents the sodium-channel route to benign familial infantile-onset
      seizures, distinct from the PRRT2 presynaptic route.
  - reference: PMID:27052163
    reference_title: PRRT2 Is a Key Component of the Ca(2+)-Dependent Neurotransmitter Release Machinery.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      PRRT2 interacts with the synaptic proteins SNAP-25 and synaptotagmin 1/2.
    explanation: >-
      Places PRRT2 in the presynaptic release machinery, defining the
      mechanistic route that must be reconciled with the ion-channel routes.
  proposed_experiments:
  - experiment_id: exp_bfie_multigene_convergence_screen
    name: BFIE multi-gene convergence electrophysiology screen
    description: >-
      In a shared infantile cortical-network assay, compare PRRT2 loss,
      familial SCN2A and SCN8A alleles, and ANKH c.-11C>T for a common signature
      of increased network synchrony and excitatory/inhibitory imbalance,
      testing whether the distinct molecular lesions converge on one
      hyperexcitability node.
    experiment_type:
      preferred_term: comparative network electrophysiology screen
    perturbations:
    - name: PRRT2 c.649dupC loss-of-function knock-in
      target: pathophysiology#PRRT2 Loss-of-Function and Impaired Synaptic Vesicle Release
      genes:
      - preferred_term: PRRT2
        term:
          id: hgnc:30500
          label: PRRT2
      description: >-
        Introduce the recurrent PRRT2 c.649dupC loss-of-function allele in the
        shared assay background.
    - name: Familial SCN2A L1563V knock-in
      target: pathophysiology#SCN2A Nav1.2 Variant-Specific Excitability
      genes:
      - preferred_term: SCN2A
        term:
          id: hgnc:10588
          label: SCN2A
      description: >-
        Introduce the familial SCN2A L1563V allele in the same assay background.
    - name: Familial SCN8A p.E1483K knock-in
      target: pathophysiology#SCN8A Nav1.6 Familial Epilepsy Association
      genes:
      - preferred_term: SCN8A
        term:
          id: hgnc:10596
          label: SCN8A
      description: >-
        Introduce the recurrent familial SCN8A p.E1483K allele in the same assay
        background.
    - name: ANKH c.-11C>T start-region knock-in
      target: pathophysiology#ANKH Start-Region Variant With Unresolved Epilepsy Mechanism
      genes:
      - preferred_term: ANKH
        term:
          id: hgnc:15492
          label: ANKH
      description: >-
        Introduce the recurrent ANKH c.-11C>T start-region allele in the same
        assay background.
    readouts:
    - name: Shared network hyperexcitability signature
      target: epilepsy_excitation_inhibition_imbalance:pathophysiology#Neuronal Hyperexcitability and Hypersynchrony
      biological_processes:
      - preferred_term: regulation of membrane potential
        term:
          id: GO:0042391
          label: regulation of membrane potential
        modifier: DYSREGULATED
      - preferred_term: neuronal action potential
        term:
          id: GO:0019228
          label: neuronal action potential
        modifier: INCREASED
      assays:
      - preferred_term: multielectrode array recording
      direction: POSITIVE
      interpretation: >-
        Compare network synchrony, firing, and excitability profiles across all
        four isogenic perturbations. A genuinely shared signature supports
        convergence on the conserved epilepsy hyperexcitability node; distinct
        signatures support parallel routes to the same clinical endpoint.
    controls:
    - name: Wild-type background
      description: Unperturbed matched networks.
    decision_criterion: >-
      Convergence is supported if the distinct BFIE-gene perturbations
      reproducibly produce the same network hyperexcitability signature; parallel
      routes are supported if their signatures differ despite a shared clinical
      endpoint.
    would_support:
    - epilepsy_excitation_inhibition_imbalance:pathophysiology#Neuronal Hyperexcitability and Hypersynchrony

📚

References & Deep Research